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Introduction {#sec001}
============

High levels of homocysteine (Hcy) in plasma have been associated with a variety of pathologies that expand from cardiovascular disease to hearing loss \[[@pone.0199472.ref001]--[@pone.0199472.ref004]\]. The liver, and precisely, impairments in hepatic methionine metabolism seem to be responsible of these increased plasmatic Hcy concentrations, since approximately 50% of the ingested methionine is used in this organ \[[@pone.0199472.ref005]\]. Hcy is produced in the methionine cycle, catabolized by the transsulfuration pathway and its excess is exported to the blood \[[@pone.0199472.ref006]\]. However, when there is a need of methionine, Hcy can be methylated for the synthesis of this amino acid. Three enzymes can perform Hcy methylation using different methyl donors and, among them betaine homocysteine S-methyltransferase (BHMT) uses the osmolyte betaine for this purpose \[[@pone.0199472.ref007]\]. The diet is the main source of betaine \[[@pone.0199472.ref008]\], but this metabolite can be also obtained by choline oxidation in the mitochondria \[[@pone.0199472.ref009]\]. This oxidation allows recovery of one out of the three methyl groups donated by S-adenosylmethionine for the synthesis of phosphatidylcholine from phosphatidylethanolamine in one of the hepatic processes that more S-adenosylmethionine consumes \[[@pone.0199472.ref010]\]. Therefore, BHMT becomes a link between osmoregulation, phospholipid synthesis and methionine/Hcy metabolism.

BHMT is mainly expressed in the liver \[[@pone.0199472.ref011], [@pone.0199472.ref012]\], where it constitutes \~1% of the total protein of hepatocytes \[[@pone.0199472.ref007], [@pone.0199472.ref013], [@pone.0199472.ref014]\]. Nevertheless, different levels of *Bhmt* gene expression are also detected in other rat tissues \[[@pone.0199472.ref011], [@pone.0199472.ref015], [@pone.0199472.ref016]\]. Intermediate expression levels are measured in the kidney, followed by the testis and brain, and low levels are found in the lung, cerebellum and skeletal muscle \[[@pone.0199472.ref011]\]. Moreover, in tissues with low expression levels the BHMT protein is only detected in specific cell types (i.e. Sertoli and Purkinje cells) \[[@pone.0199472.ref011]\]. *BHMT* gene expression is altered in several diseases mainly concerning the liver (i.e. cirrhosis), but also in diabetes \[[@pone.0199472.ref017]\] or Barret's esophagus \[[@pone.0199472.ref018]\]. Moreover, the presence of the protein in the lens has been associated to its role in osmoregulation, a process that is altered during cataract development \[[@pone.0199472.ref019]\].

BHMTs are highly conserved and sequences for the human and rat proteins are \~92% identical. The enzyme is a homotetramer with high thermal stability \[[@pone.0199472.ref020], [@pone.0199472.ref021]\], a property that has been used for its purification from mammalian tissues. Crystal structures show the tight binding between BHMT monomers in the dimer, as well as that of the dimers in the tetramer \[[@pone.0199472.ref022], [@pone.0199472.ref023]\]. An essential contributor to the high enzyme stability is the existence of a C-terminal α-helix (\~30 residues) that extends from one monomer towards another located immediately below or above, establishing a large number of hydrophobic interactions \[[@pone.0199472.ref020], [@pone.0199472.ref021], [@pone.0199472.ref024]\]. The rest of the subunit folds into a (α/β)~8~ barrel, where Zn^2+^ binding takes place through three cysteines and a tyrosine \[[@pone.0199472.ref022], [@pone.0199472.ref023], [@pone.0199472.ref025]\].

Classical studies have considered BHMT a cytoplasmic enzyme, but recent data show BHMT immunostaining both in the cytoplasm and the nuclear compartment in most cell types. Nevertheless, the cytoplasmic localization is preferred in hepatocytes, whereas nuclear localization is favored in tissues/cells exhibiting low expression \[[@pone.0199472.ref011]\]. Importantly, BHMT has the same oligomeric assembly in both subcellular compartments, where it is able to catalyze methionine synthesis \[[@pone.0199472.ref011]\]. In normal liver, only minute amounts of nuclear BHMT can be detected, but reductions in the cytosolic protein content together with nuclear accumulation are detected upon induction of acute liver injury with D-galactosamine or inhibition of glutathione synthesis by buthionine sulfoximine \[[@pone.0199472.ref011]\]. This anomalous nucleocytoplasmic distribution can be prevented by the administration of N-acetylcysteine or glutathione monoethyl ester, two compounds that serve as glutathione precursors and aid to the preservation of the normal GSH/GSSG ratio.

Mechanisms that have been involved in the control of nucleocytoplasmic distribution include the addition or removal of posttranslational modifications (PTMs), as well as protein-protein interactions. Datasets derived from several high-throughput studies focused on the identification of protein targets for certain PTMs or on the elucidation of the human interactome have rendered data concerning BHMT. For example, phosphorylation \[[@pone.0199472.ref026], [@pone.0199472.ref027]\], ubiquitination \[[@pone.0199472.ref028]\], acetylation \[[@pone.0199472.ref029], [@pone.0199472.ref030]\], succinylation \[[@pone.0199472.ref030]\], carbonylation \[[@pone.0199472.ref031]\], and nitrosylation \[[@pone.0199472.ref032]\] are some of the PTMs detected on BHMT in these analyses, whereas other studies also identify BHMT as a target for modification by transglutaminase \[[@pone.0199472.ref033]\]. Nevertheless, in many cases the existence of these PTMs has not been verified by additional methods, neither the enzymes catalyzing these modifications have been identified. Additionally, datasets from high-throughput experiments also showed the involvement of BHMT in some protein-protein interactions, which constitutes a surprisingly small set given the hepatic protein abundance. This list includes e.g. BHMT2 and high mobility group box 1 (HMGB1), which needs to be translocated to the cytoplasm for its interaction with BHMT \[[@pone.0199472.ref034]--[@pone.0199472.ref036]\]. Therefore, in order to expand the current network of BHMT hepatic interacting partners we have carried out a new high-throughput study using a double approach, affinity purification combined with mass spectrometry (AP-MS) and yeast two-hybrid (YTH). Here, we describe the new targets identified, as well as their validation by coimmunoprecipitation.

Materials and methods {#sec002}
=====================

Plasmid constructions and mutagenesis {#sec003}
-------------------------------------

The pTYB12-BHMT and pFLAG-BHMT plasmids containing the ORF of *R*. *norvegicus Bhmt* were described previously \[[@pone.0199472.ref011], [@pone.0199472.ref025]\]. Plasmids containing the sequences of BHMT interaction targets were prepared from Image clones containing the complete ORFs that were purchased from Source Bioscience Geneservice (Nottingham, UK). Exceptions are: i) pHA-MAT containing the rat *Mat1a* ORF that was previously described \[[@pone.0199472.ref037]\]; ii) pHA-MAT2A that was obtained by NdeI/EcoRI digestion of pT7.7-MAT2A \[[@pone.0199472.ref038]\], cloning of the ORF into a modified pBluescript containing a NdeI restriction site, EcoRI digestion of pBS(NdeI)-MAT2A and ligation of the ORF in the same site of pCMV-HA (Clontech, Mountain View, CA, USA); and iii) pHA-ALDOB and pHA-HPD that were prepared from total *R*. *norvegicus* liver RNA. The ORFs were amplified using the Superscript^TM^ one-step RT-PCR kit (Invitrogen, Carlsbad, CA, USA), the primers and RT-PCR conditions described in [Table 1](#pone.0199472.t001){ref-type="table"}. Cloning into pCMV-HA (Clontech) was carried out to obtain the corresponding HA-tagged proteins, whose linker sequences are listed in [Table 2](#pone.0199472.t002){ref-type="table"}. The molecular weight of the tagged proteins was calculated using the ExPASy Compute pI/Mw tool (<http://web.expasy.org/compute_pi/>).

10.1371/journal.pone.0199472.t001

###### ORFs of BHMT interaction targets, PCR programs and primers used for amplification.

![](pone.0199472.t001){#pone.0199472.t001g}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Protein code or name                               Source or IMAGE clone   origin                                   Amplification primers[^a^](#t001fn001){ref-type="table-fn"}   Restriction sites   PCR\
                                                                                                                                                                                                        program
  -------------------------------------------------- ----------------------- ---------------------------------------- ------------------------------------------------------------- ------------------- -----------------------------------------
  A7VJC2                                             2822109                 human                                    `5’-cggaattcgaaatcgggctgaagcgact-3’`                          **EcoRI KpnI**      95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 56° 1 min; 72°C 90s) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-ggggtaccgtgaagcccatggcaaatag-3’`                                                                                                                                                                  

  Q9ESW0                                             3845478                 human                                    `5’-ggggtaccttcgcttgtgtccctctttct-3’`                         **KpnI NotI**       95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 56° 1 min; 72°C 210s) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-atagtttagcggccgcctttggggagggtcagca-3’`                                                                                                                                                            

  O88902[^b^](#t001fn002){ref-type="table-fn"}       6579163                 human                                    `5’-cggaattcggcgattcggcacgag-3’`                              **EcoRI XhoI**      95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 56°C 60s; 72°C 3 min) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-cgtgcgctcgagcag-3’`                                                                                                                                                                               

  `5’- ccgctcgagcgcacgcagt-3’`                       **XhoI XhoI**           95°C 2 min\                                                                                                                
                                                                             (95°C 30s; 56°C 60s; 72°C 3 min) x 30\                                                                                     
                                                                             72°C 10min                                                                                                                 

  `5’-tcgctcgagaggaccaggtaggcaaaacc-3’`                                                                                                                                                                 

  P60711                                             6920838                 rat                                      `5’-cggaattcacaaccttcttgcagctcctc-3’`                         **EcoRI KpnI**      95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 56° 1 min; 72°C 90s) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-ggggtaccaagggtgtaaaacgcagctc-3’`                                                                                                                                                                  

  Q6DUV1                                             40028213                human                                    `5’-ggggtaccccgaccatggtagtgttcaa-3’`                          **KpnI NotI**       95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 55° 1 min; 72°C 150s) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-ataatttagcggccgccatcggcaaagtccaactg-3’`                                                                                                                                                           

  Q9JLS3                                             9020643                 human                                    `5’-cgagatctgccaggccccactctcagg-3’`                           **BglII NotI**      95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 56° 1 min; 72°C 4 min) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-ataatttagcggccgcctggaagggctggagtcag-3’`                                                                                                                                                           

  Q56R17                                             4834709                 human                                    `5’-ggggtaccacgggggaaggagtcacc-3’`                            **KpnI NotI**       95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 58° 1 min; 72°C 90s) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-atagtttagcggccgcgctgcattgtacctaacttcca-3’`                                                                                                                                                        

  P23514                                             5599357                 rat                                      `5’-ggggtaccgccatgaccgcagctgagaa-3’`                          **KpnI NotI**       95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 56° 1 min; 72°C 210s) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-atagtttagcggccgcacactttcgaggaccgtttg-3’`                                                                                                                                                          

  P63018                                             7104230                 rat                                      `5’-cggaattcaagcctacacgcaagcaacc-3’`                          **EcoRI KpnI**      95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 56° 1 min; 72°C 120s) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-ggggtaccgaacaatgctataccctctactttga-3’`                                                                                                                                                            

  P62961                                             7105037                 rat                                      `5’-ggggtaccacagtcaccatcaccgcaac-3’`                          **KpnI NotI**       95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 54° 1 min; 72°C 1 min) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-atagtttagcggccgcgaccaaaccggatgatggta-3’`                                                                                                                                                          

  P13383                                             7109097                 rat                                      `5’-cggaattcccgccatcatggtgaaa-3’`                             **EcoRI NotI**      95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 55° 1 min; 72°C 150s) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-ataatttagcggccgcctattcaaacttcgtcttctttcc-3’`                                                                                                                                                      

  P14659                                             7112083                 rat                                      `5’-cggaattcattggtcactccgaccagtca-3’`                         **EcoRI KpnI**      95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 56° 1 min; 72°C 120s) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-ggggtaccaggtttacgcggactccag-3’`                                                                                                                                                                   

  B1WC97                                             7114289                 rat                                      `5’-cggaattctactgcttgactttagttcttcagg-3’`                     **EcoRI KpnI**      95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 56° 1 min; 72°C 1 min) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-ggggtaccgattcttgtttcccaggacaat-3’`                                                                                                                                                                

  B4F7A9                                             7114331                 rat                                      `5’-ggggtaccacagtttcggtccggattc-3’`                           **KpnI NotI**       95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 56° 1 min; 72°C 90s) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-atagtttagcggccgcgaggaaccgcaacagacc-3’`                                                                                                                                                            

  P63159                                             7128547                 rat                                      `5’-cggaattctcgcggaggaaaatcaactaa-3’`                         **EcoRI KpnI**      95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 56° 1 min; 72°C 1 min) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-ggggtaccgggggttaaatgctttatagacaa-3’`                                                                                                                                                              

  Q5XIQ3                                             7134100                 rat                                      `5’-cggaattcaagcagtttgcaggctctcc-3’`                          **EcoRI KpnI**      95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 56° 1 min; 72°C 1 min) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-ggggtaccgagggcagctttgggttc-3’`                                                                                                                                                                    

  P27791                                             7314651                 rat                                      `5’-ggggtacccagccgcgtcgcagctc-3’`                             **KpnI NotI**       95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 62° 1 min; 72°C 90s) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-atagtttagcggccgcagaaaacccatggggcaca-3’`                                                                                                                                                           

  P04256                                             7374689                 rat                                      `5’-cggaattcaacgctctcatcatcctaccg-3’`                         **EcoRI KpnI**      95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 56° 1 min; 72°C 1 min) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-ggggtaccaagctttgtttcctggctgt-3’`                                                                                                                                                                  

  Q4V8C1                                             7456915                 rat                                      `5’-ggggtaccggacttctcaccccaaacct-3’`                          **KpnI NotI**       95°C 2 min\
                                                                                                                                                                                                        (95°C 30s; 58° 1 min; 72°C 90s) x 30\
                                                                                                                                                                                                        72°C 10 min

  `5’-ataatttagcggccgcgcaagttgagaccttgcac-3’`                                                                                                                                                           

  ALDOB                                              Liver RNA               rat                                      `5’-cgaattccgatggctcaccgatttccag-3’`                          **EcoRI XhoI**      50°C 30 min\
                                                                                                                                                                                                        94°C 2 min\
                                                                                                                                                                                                        (94°C 15s; 58°C 30s; 70°C 75s) x 36\
                                                                                                                                                                                                        72°C 10 min

  `5’-ccgctcgagggtgacggtatctagtagg-3’`                                                                                                                                                                  

  HPD                                                Liver RNA               rat                                      `5’-cgaattccgatgacaacctacagcaac-3’`                           **EcoRI XhoI**      50°C 30 min\
                                                                                                                                                                                                        94°C 2 min\
                                                                                                                                                                                                        (94°C 15s; 40°C 30s; 70°C 75s) x 36\
                                                                                                                                                                                                        72°C 10 min

  `5’-ccgctcgagttacattccagacctcac-3’`                                                                                                                                                                   
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^restriction sites appear underlined

^b^amplification of two fragments containing XhoI restriction sites was done independently and the whole ORF obtained upon ligation

10.1371/journal.pone.0199472.t002

###### Linkers of the HA-tagged proteins used in this study.

![](pone.0199472.t002){#pone.0199472.t002g}

  Protein code or name   No linker residues   Amino acid sequence of the linker        Tagged protein size (kDa)[^a^](#t002fn001){ref-type="table-fn"}
  ---------------------- -------------------- ---------------------------------------- -----------------------------------------------------------------
  A7VJC2                 18                   LMAMEARIRNRAEATESA                       40.69
  Q9ESW0                 38                   LMAMEARIRSTEISRGTFACVPLSSVALESRRAAPSLD   42.77
  O88902                 21                   LMAMEARIRRFGTRGRRVPAA                    167.07
  P60711                 26                   LMAMEARIHNLLAAPPSPVHTRHQFA               45.84
  Q6DUV1                 19                   LMAMEARIRSTEISRGTPT                      86.89
  Q9JLS3                 25                   LMAMEARIRSTEICQAPLSGPPGAT                142.55
  Q56R17                 26                   LMAMEARIRSTEISRGTTGEGVTGPA               61.81
  P23514                 18                   LMAMEARIRSTEISRGTA                       110.20
  P63018                 15                   LMAMEARIQAYTQAT                          73.77
  P62961                 24                   LMAMEARIRSTEISRGTTVTITAT                 39.54
  P13383                 11                   LMAMEARIPAI                              79.56
  P14659                 16                   LMAMEARIHWSLRPVR                         72.80
  B1WC97                 34                   LMAMEARILLLDFSSSGLRPPAYPKPRPPPRARG       38.05
  B4F7A9                 31                   LMAMEARIRSTEISRGTTVSVRIPGIPVPPA          45.70
  P63159                 16                   LMAMEARILAEENQLN                         27.94
  Q5XIQ3                 25                   LMAMEARIQAVCRLSQQRGLGLGPT                36.52
  P27791                 33                   LMAMEARIRSTEISRGTQPRRSSGTGPGRDAAA        45.30
  P04256                 16                   LMAMEARIQRSHHPTV                         37.29
  Q4V8C1                 26                   LMAMEARIRSTEISRGTGLLTPNLPL               46.95
  MATα1                  9                    LMAMEAEFH                                45.86
  MATα2                  13                   LMAMEARIPLWHH                            46.46
  HPD                    9                    LMAMEARIP                                47.34
  ALDOB                  9                    LMAMEARIP                                41.75

^a^Calculated using ExPASy tools

Plasmids for YTH were prepared from pBS-BHMT that contains the ORF of rat *Bhmt* \[[@pone.0199472.ref025]\]. For this purpose, pBS-BHMT was NdeI/BamHI digested and the ORF cloned into the same sites on pGBKT7 (Clontech) to render pGBKT7-BHMT. Cloning into pACT2 (Clontech) required site-directed mutagenesis of pBS-BHMT to create a NcoI restriction site using the QuikChange method and the primers `5’-GATATCGAATTCCATGGCACCGATTGCC-3’` (sense; NcoI site underlined) and its complementary. The mutated plasmid was NcoI/BamHI digested and cloned into pACT2 to obtain pACT2-BHMT. Sequences were verified by automatic sequencing at the Genomic Service of the Instituto de Investigaciones Biomédicas "Alberto Sols" (IIBM).

Production of intein and intein-BHMT {#sec004}
------------------------------------

Competent *E*. *coli* BL21(DE3) cells were transformed with either pTYB12 or pTYB12-BHMT and grown in LB plates containing 50 μg/ml ampicillin (LBA). A single colony was used to inoculate 100 ml of LBA medium that was grown overnight at 37°C. This culture was used to inoculate 3 liters of LBA medium that were further incubated at 37°C to reach A~600~\~0.9. At this point, expression of the proteins was induced by addition of 0.5 mM IPTG overnight at 22°C. Cells were harvested by centrifugation and the pellet was divided in aliquots (1 g) for storage at -80°C.

Bacteria overexpressing intein (6 g) or intein-BHMT (2 g) were lysed on ice in 20 mM Tris/HCl pH 8, 500 mM NaCl, 0.1 mM EDTA, 0.1% Triton X-100 (buffer A) containing protease inhibitors (2 μg/ml aprotinin, 1 μg/ml pepstatin A, 2.5 μg/ml antipain, 0.5 μg/ml leupeptin, 0.1 mM PMSF, 0.1 mM benzamidine) in a Branson 250 sonifier (30 cycles on/off 30s; out power level 8). Lysates were cleared by centrifugation at 13000 xg for 30 min at 4°C, the supernatants collected and used to load chitin columns (New England Biolabs, Ipswich, MA, USA).

Preparation of liver cytosolic samples {#sec005}
--------------------------------------

Male *R*. *norvegicus* Wistar (\~250g; N = 10) received standard diets *ad libitum* and were euthanized by CO~2~ asphyxiation. The livers were immediately extracted, washed with PBS and frozen using liquid nitrogen for storage at -80°C. Cytosolic fractions were prepared immediately before use by homogenization of liver samples (10 g) in 20 ml of 10 mM sodium phosphate buffer pH 7.4, 5 mM EDTA, 0.1 mM EGTA (buffer B) containing protease inhibitors (2 μg/ml aprotinin, 1 μg/ml pepstatin A, 2.5 μg/ml antipain, 0.5 μg/ml leupeptin, 0.1 mM PMSF, 5 mM benzamidine and 10 μg/ml soybean trypsin inhibitor). Homogenates were centrifuged at 15000 xg 20 min at 4°C and the supernatant centrifuged for 1h at 105000 xg and 4°C to obtain the cytosols. The experiments included in this study were approved by the CSIC Bioethics Committee and carried out in full accordance with Spanish regulations (RD 53/2013) and the European Community guidelines (2010/63/EU) for the use of laboratory animals.

Preparation of columns and isolation of protein interaction targets {#sec006}
-------------------------------------------------------------------

Three columns containing chitin beads (New England Biolabs) were prepared for each of the nine independent experiments carried out. Column 1 (4 ml) was equilibrated with buffer B, whereas columns 2 (4 ml) and 3 (1 ml) were equilibrated in buffer A and loaded with intein and intein-BHMT lysates, respectively. After binding of the baits, columns 2 and 3 were also equilibrated in buffer B before loading of rat liver protein samples. All columns were run at 10 ml/h and 4°C.

Column 1 was loaded with liver cytosol and the flowthrough collected and loaded into column 2. The flowthrough of this second column was also collected and loaded into column 3. The three columns were then extensively washed with buffer B until A~280~ \~0. At this point elution of the proteins bound was carried out with a gradient from 0--500 mM NaCl (40 column volumes). Fractions (5 ml for columns 1 and 2; 1 ml for column 3) were collected during all the process and A~280~ recorded. Columns 2 and 3 were later incubated with 3 column volumes of buffer B containing 30 mM 2-mercaptoethanol for 48 h at 23°C for intein excision, allowing recovery of strong interactors together with BHMT. Samples (50 μl) of the loaded cytosols and flowthroughs, as well as from the eluted peaks were separated on 10% SDS-PAGE gels, which were later stained with Coomassie Blue. Protein peaks were washed extensively with 20 mM ammonium acetate pH 7.7 using PM-10 membranes (AMICON Inc. Beverly, MA, USA). The concentrated protein pools were then lyophilized, reconstituted with water (50 μl) and divided in aliquots to measure protein concentration and to prepare for SDS-PAGE (10--30 μg/lane) by addition of Laemmli buffer.

Mass spectrometry detection of protein interaction targets {#sec007}
----------------------------------------------------------

Proteins were in-gel digested using a previously described protocol \[[@pone.0199472.ref039]\]. Briefly, identical amounts of each protein sample were suspended in sample buffer and loaded in 2.8-cm-wide wells of an SDS-PAGE gel. The run was stopped as the front entered 3 mm into the resolving gel. The protein band was visualized by Coomassie Blue staining, excised, and digested overnight at 37°C with 60 ng/l trypsin (Promega, Madison, WI, USA; Cat. No. V5111) at a 5:1 (w/w) protein:trypsin ratio in 50 mM ammonium bicarbonate pH 8.8, containing 10% (v/v) acetonitrile and 0.01% (w/v) 5-cyclohexyl-1-pentyl-D-maltoside (Fluka; Cat. No. 96193). The supernatant was recovered and the gel pieces incubated with 12 mM ammonium bicarbonate pH 8.8 for 1 hour. Both supernatants were combined and 25% (v/v) trifluoroacetic acid (Merck, Darmstadt, Germany; Cat. No. 808260) added until pH 3. Peptides were finally desalted using OMIX tips (Varian Inc., Walnut Creek, CA, USA; Cat. No. A57003100) following manufacturer's instructions and dried down. Isolated peptides were analyzed by LC-MS/MS using a Surveyor LC system coupled to a linear ion trap mass LTQ spectrometer (Thermo Fisher) as previously described \[[@pone.0199472.ref040]\]. The LTQ was operated in a data-dependent MS/MS mode using the 15 most intense precursors detected in a survey scan from 400 to 1,600 m/z \[[@pone.0199472.ref040], [@pone.0199472.ref041]\]. Number of microscans, normalized collision energy, and dynamic exclusion parameters were as previously described \[[@pone.0199472.ref040], [@pone.0199472.ref041]\]. Protein identification was carried out as described previously using the SEQUEST algorithm (Bioworks 3.2 package, Thermo Finnigan) \[[@pone.0199472.ref040], [@pone.0199472.ref042]\]. The MS/MS raw files were searched against the Rat Uniprot database (UniProt release 06/2009) supplemented with porcine trypsin and human keratin. The same collections of MS/MS spectra were also searched against inverted databases constructed from the same target databases. SEQUEST results were analyzed using the probability ratio method \[[@pone.0199472.ref043]\], and false discovery rates (FDR) were calculated using the refined method \[[@pone.0199472.ref044]\]. Peptide and scan counting was performed assuming as positive events those with an FDR lower than 5%.

Yeast two-hybrid {#sec008}
----------------

Screening for BHMT interactions was carried out with a rat liver Matchmaker cDNA library (RL4004AH; Clontech) and the AH109 yeast strain. Transformation was performed with EasyComp solutions (Invitrogen) and selection achieved using low (-Leu/-Trp; LW) and high stringency (-Ade/-His/-Leu/-Trp; -AHLW) SC media for growth of the resulting transformants. Screening of 1.5 x 10^7^ clones was carried out and 52 putative interactions detected, from which only 38 were confirmed in--AHLW SC medium. DNAs of the positive clones were isolated and used to transform *E*. *coli* DH5α competent cells. Plasmids were purified with Qiagen plasmid purification kits (Qiagen, Hilden, Germany) and sequenced at the IIBM Genomic Service. Fourteen biologically relevant preys were found, the rest corresponding to BHMT-BHMT interactions; this large background was expected from the homo-oligomeric association state of BHMT and guarantees native folding of the fusion protein used for screening. Verification of positive interactions was carried out by cotransformation of plasmids harboring the *Bhmt* ORF and putative preys and growth on--AHLW SC media.

Transient transfections and immunoprecipitation procedures {#sec009}
----------------------------------------------------------

Commercial COS-7 (monkey kidney), N2a (mouse neuroblastoma) or H35 (rat hepatoma) cell lines were obtained from the IIBM collection and originally purchased from the ATCC. Cells were grown in DMEM (Gibco, Carlsbad, CA, USA) supplemented with 10% (v/v) fetal bovine serum and 2 mM glutamine. Cells (2x10^6^) were transfected using lipofectamine (Invitrogen) for 6 hours using pFLAG-BHMT, pHA-prey plasmids or cotransfected with pFLAG-BHMT/pHA-prey plasmids (10 μg) at 1:1 ratios. Total lysates were prepared 48 hours after transfection in 200 μl of 50 mM Tris/HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% (v/v) NP-40, 1 mM DTT containing 1 mM PMSF, 1 mM benzamidine, 2 μg/ml aprotinin, 1 μg/ml pepstatin A, 0.5 μg/ml leupeptin, 2.5 μg/ml antipain (immunoprecipitation buffer) by incubation on ice for 10 min, followed by six passages through a 25G syringe. Input samples were taken at this step, whereas the remaining sample was centrifuged for 15 min at 10000 xg and 4°C.

Cellular fractions (150 μl total lysates or 100 μl cytosolic fractions) were incubated o/n at 4ºC with mouse monoclonal anti-FLAG M2 Agarose (50 μl; Sigma, St. Louis, MI, USA; Cat. No. A2220) for anti-FLAG immunoprecipitation. On the other hand, the cellular fractions were precleared using anti-mouse IgG (2 μg) for 2 hours at 4°C before anti-HA immunoprecipitation as previously described \[[@pone.0199472.ref045]\]. Samples were then centrifuged for 15 min at 10000 xg before overnight incubation with mouse monoclonal anti-HA (2 μg, Covance; Cat. No. MMS-101R) coupled to protein A Sepharose CL-4B (GE Healthcare, Uppsala, Sweden) at 4°C. The beads were washed 3 times with immunoprecipitation buffer and later boiled in Laemmli sample buffer (40 μl) containing 100 mM DTT for 10 min. Following centrifugation for 5 min at 10000 xg, the supernatants were loaded on SDS-PAGE gels and proteins were electrotransferred to nitrocellulose membranes for immunoblotting.

Immunoblotting {#sec010}
--------------

Membranes were incubated with mouse monoclonal anti-FLAG M2 (5 μg/ml, Sigma; Cat. No. F3165), mouse monoclonal anti-HA (1:1000 v/v, Covance; Cat. No. MMS-101R) or rabbit polyclonal anti-BHMT (1:20000 v/v) \[[@pone.0199472.ref025]\] as required. To avoid hindrance with mouse immunoglobulin bands after anti-FLAG or anti-HA immunoprecipitation, mouse TrueBlot ULTRA (1:1000 v/v, eBioscience; Cat. No. 18--8817) was used. Proteins were visualized using Western Lightning™ chemiluminescence reagent (Perkin Elmer, Waltham, MA, USA). The images were scanned and quantification carried out using ImageJ software.

Determination of protein concentration {#sec011}
--------------------------------------

The protein concentration of the samples was measured using the Bio-Rad protein assay kit and bovine serum albumin as the standard.

Protein-protein interaction network and statistical analysis {#sec012}
------------------------------------------------------------

The list of BHMT-protein interactors obtained by AP-MS and YTH was analyzed using STRING (<https://string-db.org/>) and Bioprofiling ([http://www.bioprofiling.de](http://www.bioprofiling.de/)) tools for the identification of protein-protein interaction networks \[[@pone.0199472.ref046]--[@pone.0199472.ref048]\]. Student's t-test for unpaired samples was applied for statistical analysis using GraphPad Prism v. 5.0 (GraphPad Software, San Diego, CA, USA). Data are shown as the mean ± SEM and differences were considered significant when p≤0.05.

Results {#sec013}
=======

The search for BHMT interaction targets was performed initially by AP-MS using liver cytosols of Wistar rats. Elimination of unspecific interactors was carried out by sequential passages through control (beads only) and intein columns, before loading onto intein-BHMT columns ([Fig 1](#pone.0199472.g001){ref-type="fig"}). Proteins bound to each column were then eluted using a salt gradient and the A~280~ registered. For the three columns, the absorption profiles showed a single peak between 50--100 mM NaCl that was collected ([Fig 2](#pone.0199472.g002){ref-type="fig"}). Elution of stronger interactors required excision of the intein-BHMT tag by incubation with a reducing agent. In this case, BHMT (45 kDa) was recovered together with its strong interacting partners as observed in the corresponding gels ([Fig 2E](#pone.0199472.g002){ref-type="fig"}); again, the pools were collected. Identification of the proteins bound in each case was carried out after trypsinization by mass spectrometry. First, comparison between datasets corresponding to control and intein columns versus datasets of the intein-BHMT column was performed for proteins eluting with the salt gradient. Sixty-nine potential BHMT interaction targets were identified, which showed the same binding behavior in independent experiments ([Table 3](#pone.0199472.t003){ref-type="table"} and [S1 Table](#pone.0199472.s001){ref-type="supplementary-material"}). The same analysis was carried out for stronger interactors eluting upon excision of the intein tag and 59 putative interaction targets were identified in several experiments ([Table 4](#pone.0199472.t004){ref-type="table"} and [S1 Table](#pone.0199472.s001){ref-type="supplementary-material"}). Nevertheless, some targets of potential interest that were found only in one experiment were considered also for further validation. Among them, proteins of the methionine cycle, MATα1, MATα2 and BHMT2.

![Schematic representation of the affinity purification/mass spectrometry procedure.\
Three chitin columns were used: column 1 contained only the beads (4 ml); column 2 contained intein bound to the beads (4 ml); and column 3 has intein-BHMT bound to the beads (1 ml). Liver cytosol was loaded on column 1, the flowthrough recovered and loaded on column 2 and the flowthrough of this last column loaded on column 3. Elution of the proteins bound to each of the columns was first performed with a salt gradient and finally, by incubation with 2-mercaptoethanol. A~280~ was measured during all the procedure to identify the eluted protein peaks that were collected and digested with trypsin for mass spectrometry identification of the interaction targets.](pone.0199472.g001){#pone.0199472.g001}

![Elution profiles from control, intein and intein-BHMT loaded chitin columns.\
The figure shows representative A~280~ elution profiles from control (beads only; 4 ml), intein (4 ml) and intein-BHMT (1 ml) loaded chitin columns, as well as representative Coomassie Blue stained SDS-PAGE gels of liver cytosol, flowthroughs loaded on these columns and samples of the eluted peaks. (A) Control columns were loaded with liver cytosol and eluted with a NaCl gradient. (B) The flowthrough from the control column was loaded onto the intein column and elution performed with the same salt gradient. (C) The flowthrough of the intein column was loaded onto the intein-BHMT column and elution carried out with a NaCl gradient. (D) SDS-PAGE of the protein fractions loaded onto the columns: liver cytosol (2 μl); flowthrough of the chitin column (2 μl); flowthrough of the intein column (2 μl); and flowthrough of the intein BHMT column (2 μl). (E) Eluted proteins using salt gradients and 2-mercaptoethanol (2-ME) excision were collected and analyzed by SDS-PAGE: chitin peak (40 μl); intein peak (40 μl); and intein-BHMT peak (40 μl). Molecular weight standards are shown on the right side of each gel.](pone.0199472.g002){#pone.0199472.g002}

10.1371/journal.pone.0199472.t003

###### Candidates for BHMT interaction identified by mass spectrometry after affinity purification on chitin columns eluted with a salt gradient.

![](pone.0199472.t003){#pone.0199472.t003g}

  Uniprot code                                           Protein
  ------------------------------------------------------ -----------------------------------------------------------------------------------------------
  **P13444**[^**a**^](#t003fn001){ref-type="table-fn"}   **S-adenosylmethionine synthase isoform type-1, MATα1**
  **P18298**                                             **S-adenosylmethionine synthase isoform type-2, MATα2**
  Q5U2R0                                                 Methionine adenosyltransferase 2 subunit beta, MAT**β**[^b^](#t003fn002){ref-type="table-fn"}
  Q6P688                                                 S-adenosylmethionine synthase, MAT**α**2[^b^](#t003fn002){ref-type="table-fn"}
  Q63432                                                 RAT Rat protein kinase C-family related[^b^](#t003fn002){ref-type="table-fn"}
  **Q6DUV1**                                             **RAT Protein kinase C epsilon type**[^b^](#t003fn002){ref-type="table-fn"}
  **B4F7A9**                                             **Casein kinase 2 α2**
  Q9JIH7                                                 Serine/threonine-protein kinase WNK1
  **O88902**                                             **Tyrosine-protein phosphatase non-receptor type 23, PTPN23**
  **Q5XIQ3**                                             **CXXC-type zinc finger protein 5, CXXC5**
  **P60711**                                             **ACTB Actin, cytoplasmic 1 (Beta-actin).**
  **Q4V8C1**                                             **RGD1306462 protein**
  **P14659**                                             **HSP72 Heat shock-related 70 kDa protein 2**
  **P63018**                                             **HSP7C Heat shock cognate 71 kDa protein**
  **Q56R17**                                             **Importin subunit alpha, Karyopherin alpha 4**[^b^](#t003fn002){ref-type="table-fn"}
  **B1WC97**                                             **BTB/POZ domain-containing protein KCTD7**
  **P23514**                                             **Coatomer subunit beta**
  **A7VJC2**                                             **Heterogeneous nuclear ribonucleoproteins A2/B1**
  **P04256**                                             **Heterogeneous nuclear ribonucleoprotein A1**
  **P63159**                                             **High mobility group protein B1 (HMGB-1)**
  **P13383**                                             **Nucleolin**
  **P62961**                                             **Nuclease-sensitive element-binding protein 1**
  **Q9ESW0**                                             **DNA damage-binding protein 1**
  P52925                                                 High mobility group protein 2 (HMGB-2)
  P17132                                                 Heterogeneous nuclear ribonucleoprotein D0
  Q6URK4                                                 Heterogeneous nuclear ribonucleoprotein A3
  Q8VHV7                                                 Heterogeneous nuclear ribonucleoprotein H
  Q66HM7                                                 Sjogren syndrome antigen B, SSB
  P13084                                                 Nucleophosmin
  P52590                                                 Nuclear pore complex protein Nup107[^b^](#t003fn002){ref-type="table-fn"}
  P43138                                                 DNA-(apurinic or apyrimidinic site) lyase, APEX1
  Q63396                                                 Activated RNA polymerase II transcriptional coactivator p15
  Q6AY09                                                 Heterogeneous nuclear ribonucleoprotein H2
  B0BN99                                                 High mobility group box 3, Hmgb3
  B0BNC9                                                 Quinone oxidoreductase-like protein 2
  O35796                                                 C1QBP Complement component 1 Q subcomponent-binding protein, mitochondrial
  Q6P6R6                                                 Transglutaminase 2, C polypeptide[^b^](#t003fn002){ref-type="table-fn"}
  Q9WVJ6                                                 Tissue-type transglutaminase[^b^](#t003fn002){ref-type="table-fn"}
  P17764                                                 Acetyl-CoA acetyltransferase, mitochondrial
  P28042                                                 SSBP1 Single-stranded DNA-binding protein, mitochondrial
  B0BND0                                                 ENPP6 Ectonucleotide pyrophosphatase/phosphodiesterase family member 6
  Q672K1                                                 NADPH oxidase 3[^b^](#t003fn002){ref-type="table-fn"}
  P35281                                                 RAB10 Ras-related protein Rab-10[^b^](#t003fn002){ref-type="table-fn"}
  Q7TPK6                                                 Serine/threonine-protein kinase WNK4[^b^](#t003fn002){ref-type="table-fn"}
  Q9Z286                                                 Adenylate cyclase type 10[^b^](#t003fn002){ref-type="table-fn"}
  Q6IMF3                                                 Keratin, type II cytoskeletal 1
  Q5EAP4                                                 Guanine nucleotide binding protein, alpha 14
  P04785                                                 Protein disulfide-isomerase[^b^](#t003fn002){ref-type="table-fn"}
  P06761                                                 78 kDa glucose-regulated protein[^b^](#t003fn002){ref-type="table-fn"}
  P13107                                                 Cytochrome P450 2B3[^b^](#t003fn002){ref-type="table-fn"}
  Q6LCX1                                                 Cytochrome P450 2B3[^b^](#t003fn002){ref-type="table-fn"}
  P07896                                                 ECHP Peroxisomal bifunctional enzyme
  Q9Z2M4                                                 DECR2 Peroxisomal 2,4-dienoyl-CoA reductase
  Q6AYD3                                                 Proliferation-associated protein 2G4
  B2RYX0                                                 Naca protein
  A1A5S1                                                 Pre-mRNA splicing factor 6
  Q6WAY2                                                 Phospholipid phosphatase-related protein type 1
  P47245                                                 Nardilysin
  Q6VV72                                                 Eukaryotic translation initiation factor 1A
  B1H281                                                 LOC499754 protein
  B5DFF5                                                 Triobp protein
  O88311                                                 AlF-C1
  B0LT89                                                 Serine/threonine-protein kinase 24[^b^](#t003fn002){ref-type="table-fn"}
  P12749                                                 60S ribosomal protein L26
  P62864                                                 40S ribosomal protein S30 (Fau)
  Q07205                                                 Eukaryotic translation initiation factor 5
  B2RZB7                                                 Small nuclear ribonucleoprotein D1
  B5DEN5                                                 Eukaryotic translation elongation factor 1 beta 2
  Q9QYQ9                                                 Homeobox protein

^a^In bold, proteins selected for validation by immunoprecipitation.

^b^Proteins that are found in only one experiment, but are related to BHMT protein function, subcellular localization or previously described as BHMT protein-protein interaction targets.

10.1371/journal.pone.0199472.t004

###### Candidates for BHMT interaction identified by mass spectrometry after affinity purification on chitin columns eluted with 2-mercaptoethanol.

![](pone.0199472.t004){#pone.0199472.t004g}

  Uniprot code                                           Protein
  ------------------------------------------------------ -----------------------------------------------------------------------------------------------------
  **Q9JLS3**[^**a**^](#t004fn001){ref-type="table-fn"}   **Serine/threonine-protein kinase TAO2**
  **P27791**[^**a**^](#t004fn001){ref-type="table-fn"}   **cAMP-dependent protein kinase catalytic subunit alpha**[^b^](#t004fn002){ref-type="table-fn"}
  **O88902**[^**a**^](#t004fn001){ref-type="table-fn"}   **Tyrosine-protein phosphatase non-receptor type 23**
  P51577                                                 P2X purinoceptor 4
  Q62969                                                 Prostacyclin synthase
  A1A5S1                                                 Pre-mRNA splicing factor 6
  Q6WAY2                                                 Phospholipid phosphatase-related protein type 1
  Q5BK24                                                 Uncharacterized protein C8orf76 homolog
  Q3T1I3                                                 Usher syndrome type-1C protein-binding protein 1
  B2GV26                                                 LOC304239 protein
  Q5BJT0                                                 Arginine and glutamate-rich protein 1[^b^](#t004fn002){ref-type="table-fn"}
  Q5XIC3                                                 Hsp90 co-chaperone Cdc37-like 1[^b^](#t004fn002){ref-type="table-fn"}
  A2IA98                                                 40S ribosomal protein S3[^b^](#t004fn002){ref-type="table-fn"}
  O08875                                                 Serine/threonine-protein kinase DCLK1[^b^](#t004fn002){ref-type="table-fn"}
  P52796                                                 Ephrin-B1[^b^](#t004fn002){ref-type="table-fn"}
  P97531                                                 Cdc42-interacting protein 4[^b^](#t004fn002){ref-type="table-fn"}
  Q00939                                                 Forkhead box protein G1[^b^](#t004fn002){ref-type="table-fn"}
  Q5SGD7                                                 Connector enhancer of kinase suppressor of ras 3[^b^](#t004fn002){ref-type="table-fn"}
  B2GUW9                                                 RGD1562161 protein[^b^](#t004fn002){ref-type="table-fn"}
  B5DFC1                                                 Vps35 protein[^b^](#t004fn002){ref-type="table-fn"}
  Q4V8M7                                                 LOC304239 protein[^b^](#t004fn002){ref-type="table-fn"}
  Q5BJR5                                                 Microspherule protein 1[^b^](#t004fn002){ref-type="table-fn"}
  Q5U2M4                                                 DNA ligase[^b^](#t004fn002){ref-type="table-fn"}
  Q6P7B6                                                 Ephrin B1[^b^](#t004fn002){ref-type="table-fn"}
  Q8CH93                                                 Hyaluronan synthase 1[^b^](#t004fn002){ref-type="table-fn"}
  Q8QZV1                                                 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A[^b^](#t004fn002){ref-type="table-fn"}
  Q9QYU6                                                 Zinc finger protein[^b^](#t004fn002){ref-type="table-fn"}
  Q80W87                                                 Roundabout homolog 4[^b^](#t004fn002){ref-type="table-fn"}
  A0JPQ3                                                 Microtubule associated scaffold protein 2[^b^](#t004fn002){ref-type="table-fn"}
  O35762                                                 Homeobox protein Nkx-6.1[^b^](#t004fn002){ref-type="table-fn"}
  Q07936                                                 Annexin A2[^b^](#t004fn002){ref-type="table-fn"}
  Q5M821                                                 Protein phosphatase 1H[^b^](#t004fn002){ref-type="table-fn"}
  Q5PQK1                                                 Septin-10[^b^](#t004fn002){ref-type="table-fn"}
  Q6AXN8                                                 Zinc finger and SCAN domain containing 21[^b^](#t004fn002){ref-type="table-fn"}
  Q8VHU4                                                 Elongator complex protein 1[^b^](#t004fn002){ref-type="table-fn"}
  Q923J6                                                 Dynein heavy chain 12, axonemal[^b^](#t004fn002){ref-type="table-fn"}
  Q9EQH1                                                 GRB2-associated-binding protein 2[^b^](#t004fn002){ref-type="table-fn"}
  O70199                                                 UDP-glucose 6-dehydrogenase[^b^](#t004fn002){ref-type="table-fn"}
  P05539                                                 Collagen alpha-1(II) chain[^b^](#t004fn002){ref-type="table-fn"}
  P23457                                                 3-alpha-hydroxysteroid dehydrogenase[^b^](#t004fn002){ref-type="table-fn"}
  P32821                                                 Trypsin V-A[^b^](#t004fn002){ref-type="table-fn"}
  P60669                                                 Pleckstrin homology domain-containing family A member 4[^b^](#t004fn002){ref-type="table-fn"}
  P70673                                                 ATP-sensitive inward rectifier potassium channel 11[^b^](#t004fn002){ref-type="table-fn"}
  Q09167                                                 Serine/arginine-rich splicing factor 5[^b^](#t004fn002){ref-type="table-fn"}
  Q4V8G7                                                 Centromere protein U[^b^](#t004fn002){ref-type="table-fn"}
  Q5M7W4                                                 Transmembrane channel-like protein 5[^b^](#t004fn002){ref-type="table-fn"}
  Q5M883                                                 Chloride intracellular channel protein 2[^b^](#t004fn002){ref-type="table-fn"}
  Q62770                                                 Protein unc-13 homolog C[^b^](#t004fn002){ref-type="table-fn"}
  Q63100                                                 Cytoplasmic dynein 1 intermediate chain 1[^b^](#t004fn002){ref-type="table-fn"}
  Q6IG00                                                 Keratin, type II cytoskeletal 4[^b^](#t004fn002){ref-type="table-fn"}
  Q8K3Y6                                                 Zinc finger CCCH-type antiviral protein 1[^b^](#t004fn002){ref-type="table-fn"}
  Q9R0L4                                                 Cullin-associated NEDD8-dissociated protein 2[^b^](#t004fn002){ref-type="table-fn"}
  O35816                                                 Sodium myo-inositol transporter[^b^](#t004fn002){ref-type="table-fn"}
  Q3B8P7                                                 RCG58555, isoform CRA_a[^b^](#t004fn002){ref-type="table-fn"}
  Q5I0E7                                                 Transmembrane emp24 domain-containing protein 9[^b^](#t004fn002){ref-type="table-fn"}
  Q5RK26                                                 Polr3a protein[^b^](#t004fn002){ref-type="table-fn"}
  Q7TPK7                                                 Ac2-048[^b^](#t004fn002){ref-type="table-fn"}
  Q80WM6                                                 2\',5\'-oligoisoadenylate synthetase-dependent ribonuclease L[^b^](#t004fn002){ref-type="table-fn"}
  **Q68FT5**[^**a**^](#t004fn001){ref-type="table-fn"}   **BHMT2 S-methylmethionine homocysteine S-methyltransferase** ^**b**^

^a^In bold, proteins selected for validation by immunoprecipitation.

^b^Proteins found in only one experiment, but that are related to BHMT protein function or subcellular localization.

In parallel, YTH screening of a rat liver cDNA library was performed for the identification of additional interaction targets using the full-length ORF of rat *Bhmt* as bait. This screening rendered 14 putative preys that grew in the--AHLW high stringency SC media ([Table 5](#pone.0199472.t005){ref-type="table"}). Interestingly, seven of these putative preys were previously identified by AP-MS, namely S-methylmethionine homocysteine methyltransferase (BHMT2), transthyretin, 4-hydroxyphenylpyruvic acid dioxygenase (HPD), glutathione-S-transferase alpha type 2, alpha-2u globulin PGCL1/Major urinary protein, ornithine transcarbamylase and aldolase b protein (ALDOB). Among them, BHMT2 binds strongly to intein and intein-BHMT columns, but more peptides were recovered from peaks eluting from intein-BHMT (34 scans, 3 peptides) than from intein columns (18 scans, 2 peptides). Thus, the relevance of the BHMT-BHMT2 interaction was confirmed. Regarding the 6 remaining preys identified in the yeast two-hybrid screening and also found by AP-MS, all of them showed unspecific binding to chitin or intein columns and no peptide was found on intein-BHMT eluents, therefore their interaction with BHMT could not be validated.

10.1371/journal.pone.0199472.t005

###### Hepatic BHMT interaction targets identified by yeast two-hybrid.

![](pone.0199472.t005){#pone.0199472.t005g}

  Protein code   Protein                                                                              gene       Clones found
  -------------- ------------------------------------------------------------------------------------ ---------- --------------
  P62982         Ubiquitin-40S ribosomal protein S27a                                                 *Rps27a*   1
  P02767         Transthyretin precursor (Prealbumin)                                                 *Ttr*      1
  P09367         serine dehydratase/Sds protein                                                       *Sds*      2
  P20673         argininosuccinate lyase                                                              *Asl*      1
  P05503         cytochrome c oxidase subunit I                                                       *Mtco1*    2
  P32755         4-hydroxyphenylpyruvic acid dioxygenase                                              *Hpd*      1
  P04903         Glutathione-S-transferase, alpha type 2                                              *Gsta2*    1
  P02761         alpha-2u globulin PGCL1/Major urinary protein                                        *-*        1
  \-             Similar to Hypothetical protein BC014729                                             *-*        1
  Q6RJR6         reticulon 3 protein isoform b                                                        *Rtn3*     1
  P00481         ornithine transcarbamylase                                                           *Otc*      2
  P00884         Aldolase b protein                                                                   *Aldob*    1
  Q68FT5         hypothetical protein LOC365972/S-methylmethionine homocysteine methyltransferase 2   *Bhmt2*    3
  P02793         ferritin light chain subunit                                                         *Ftl1*     1

Twenty additional proteins were selected from AP-MS data, together with MAT**α**1, MAT**α**2, HPD and ALDOB for further validation of their interaction with BHMT by coimmunoprecipitation. For this purpose, the ORFs of interest were cloned into pCMV4-HA for expression and the size of the tagged proteins verified by immunoblotting using anti-HA ([Fig 3](#pone.0199472.g003){ref-type="fig"}). Whenever possible, the ORFs corresponded to rat proteins, but there were cases in which only the human counterpart was available. This fact was not expected to exert a major drawback given the high identity level between rat and human BHMT sequences (\~93%). Nevertheless, several proteins had to be excluded from further validation, as these HA-tagged preys did not achieve detectable expression levels in any of the cell lines used, or the size of the protein obtained differed notably from theoretical calculations. Therefore, only fourteen HA-tagged preys met the criteria for their use in coimmunoprecipitation experiments. Cotransfection with pFLAG-BHMT (47 kDa) and the pHA-prey plasmids of interest was then performed using different cell lines to ensure coexpression of both bait and prey. In several cases, expression and/or coexpression were not achieved, and hence validation of these interactions was precluded. Moreover, differences in the expression levels attained in lysates of cotransfectants and controls bearing a single plasmid were commonly observed independently of the pFLAG-BHMT/pHA-prey ratio used for transfection. These differences were taken into account for the analysis of immunoprecipitation results.

![Expression of HA-tagged candidates for interaction with BHMT.\
Several proteins identified as potential targets for BHMT interaction during yeast two-hybrid and AP-MS screenings were cloned into pCMV-HA and expressed in several cell lines to verify their molecular size. The figure shows representative images of anti-HA immunoblots of those HA-tagged proteins exhibiting the correct size upon expression in Cos7 cells; the molecular weight of the standards is indicated on the side of each blot. HPD (P32755), 4-hydroxyphenylpyruvic acid dioxygenase; MATα1, methionine adenosyltransferase α1; Q4V8C1, RGD1306462 protein; P27791, cAMP-dependent protein kinase catalytic subunit alpha; P60711, actin cytoplasmic 1; B4F7A9, casein kinase 2 alpha2; P63159, high mobility group protein B1; P04256, heterogeneous nuclear ribonucleoprotein A1; MATα2, methionine adenosyltransferase α2; P63018, heat shock cognate 71 kDa protein; P62961, nuclease-sensitive element-binding protein 1; P14659, heat shock-related 70 kDa protein 2; ALDOB (P00884), aldolase B; Q5XIQ3, CXXC-type zinc finger protein 5.](pone.0199472.g003){#pone.0199472.g003}

First, we concentrated on preys of the methionine cycle that were found by AP-MS, specifically the catalytic subunits of methionine adenosyltransferases (MATs), which are directly linked to BHMT function as consumers of methionine. Anti-FLAG immunoprecipitation from cotransfected cells allowed recovery of HA-MATα1, whereas a nonspecific background was found in immunoprecipitates of control cells overexpressing only HA-MATα1 ([Fig 4](#pone.0199472.g004){ref-type="fig"}). Changes in the composition of the buffers (e.g. salt concentration, detergents) did not reduce this background. Quantification of the HA-signals in the inputs and immunoprecipitates was carried out and their ratio (IP/input) calculated to correct for differences in expression between samples. This ratio was also significantly higher for coimmunoprecipitates, thus confirming the BHMT/MATα1 interaction. When the same procedure was used with HA-MATα2, coimmunoprecipitation with FLAG-BHMT was also detected, but a higher background was consistently observed, which is favored by the higher HA-MATα2 expression levels obtained in control cells ([Fig 5](#pone.0199472.g005){ref-type="fig"}). Nevertheless, the difference between the calculated IP/input ratios was significant, also validating the BHMT/MATα2 interaction.

![Validation of MATα1 as a BHMT interaction target.\
Cos7 cells were transfected with pFLAG-BHMT, pHA-MATα1 or cotransfected with both plasmids at a 1:1 (w/w) ratio. Lysates were obtained 48 hours posttransfection and immediately processed by anti-FLAG immunoprecipitation. Samples of the inputs (25 μl) and immunoprecipitates (40 μl) were analyzed by western blotting using specific antibodies and mouse TrueBlot. (A) Representative anti-HA immunoblots from a single immunoprecipitation experiment (N = 10). (B) Representative anti-FLAG results from a single immunoprecipitation experiment (N = 10). The size of the protein standards is indicated on the left side of each image. (C) Anti-HA signals were quantified using ImageJ and the immunoprecipitate/input ratio (mean ± SEM) for all the experiments calculated (N = 10) to correct for differences in expression between control bearing only pHA-MATα1 and cotransfectants. Statistical analysis of the data was performed by Student's t-test using GraphPad Prism; \*p≤0.05.](pone.0199472.g004){#pone.0199472.g004}

![Confirmation of MATα2 and BHMT interaction.\
Cos7 cells were transfected with pFLAG-BHMT, pHA-MATα2 or cotransfected with both plasmids at a 1:1 (w/w) ratio. Lysates were obtained 48 hours posttransfection and immediately processed by anti-FLAG immunoprecipitation. Input (25 μl) and immunoprecipitate samples (40 μl) were analyzed by western blotting using specific antibodies and mouse TrueBlot. (A) Representative anti-HA results from a single immunoprecipitation experiment (N = 8). (B) Representative anti-FLAG immunoblot from a single immunoprecipitation experiment (N = 8). The size of the protein standards is indicated on the left side of each image. (C) Anti-HA signals were quantified using ImageJ and the immunoprecipitate/input ratio (mean ± SEM) for all the experiments calculated (N = 8) to correct for differences in expression between control bearing only pHA-MATα2 and cotransfectants. Statistical analysis of the data was performed by Student's t-test using GraphPad Prism; \*p≤0.05.](pone.0199472.g005){#pone.0199472.g005}

Next, verification of the putative interaction between FLAG-BHMT and HA-tagged targets actin B (ACTB; P60711), nuclease-sensitive element-binding protein 1 (Ybx1; P62961), HMGB1 (P63159) and cAMP-dependent protein kinase catalytic subunit alpha (Prkaca; P27791) was carried out. Again, strong differences in expression levels were found between cotransfectants and controls carrying a single plasmid. Anti-FLAG and anti-HA immunoprecipitations were performed to analyze the putative interaction with HA-actin B due to the existence of unspecific signals from the anti-FLAG antibody. Nonspecific HA-actin B binding to FLAG-Sepharose reached similar levels than that detected in coimmunoprecipitates and no significant differences were found between the calculated IP/input ratios ([Fig 6](#pone.0199472.g006){ref-type="fig"}). Therefore, the BHMT/actin B interaction could not be confirmed. Similarly, coimmunoprecipitation of BHMT and Ybx1 was detected, but the high unspecific binding of Ybx1 precluded verification of this interaction ([Fig 7](#pone.0199472.g007){ref-type="fig"}). No HMGB1 signal was detected in control or coimmunoprecipitates, despite the existence of previous reports identifying this protein as a BHMT interaction partner ([Fig 8](#pone.0199472.g008){ref-type="fig"}). However, this result could be expected from the fact that the HMGB1-BHMT interaction requires translocation of HMGB1 from the nucleus to the cytoplasm, a process that was favored in previous reports. In contrast, HA-Prkaca coimunoprecipitated with FLAG-BHMT and no significant HA-signal was observed in the controls ([Fig 9](#pone.0199472.g009){ref-type="fig"}). Thus, the Prkaca was validated as a BHMT interactor.

![Corroboration of the BHMT/actin B interaction.\
Cos7 cells were transfected with pFLAG-BHMT, pHA-actin B or cotransfected with both plasmids at a 1:1 (w/w) ratio. Lysates were obtained 48 hours posttransfection and immediately processed by anti-FLAG immunoprecipitation. Input (25 μl) and immunoprecipitate samples (40 μl) were analyzed by western blotting using specific antibodies and mouse TrueBlot. (A) Representative anti-HA immunoblot from the immunoprecipitations experiments carried out (N = 7). (B) Representative anti-FLAG immunoprecipitations from the experiments performed (N = 7). The size of the protein standards is indicated on the left side of each image. (C) Anti-HA signals were quantified using ImageJ and the immunoprecipitate/input ratio (mean ± SEM) from all the experiments performed (N = 7) calculated to correct for differences in expression between control bearing only pHA-actin B and cotransfectants. Statistical analysis of the data was performed by Student's t-test using GraphPad Prism; \*p≤0.05.](pone.0199472.g006){#pone.0199472.g006}

![Testing Ybx1 as putative BHMT interaction target.\
Cos7 cells were transfected with pFLAG-BHMT, pHA-Ybx1 or cotransfected with both plasmids at a 1:1 (w/w) ratio. Lysates were obtained 48 hours posttransfection and immediately processed by anti-FLAG immunoprecipitation. Input (25 μl) and immunoprecipitate samples (40 μl) were analyzed by western blotting using specific antibodies and mouse TrueBlot. (A) Representative anti-HA images from the immunoprecipitation experiments carried out (N = 3). (B) Representative anti-FLAG immunoblot from the immunoprecipitation experiments performed (N = 3). The size of the protein standards is indicated on the left side of each image. (C) Anti-HA signals were quantified using ImageJ and the immunoprecipitate/input ratio (mean ± SEM) from all the experiments (N = 3) calculated to correct for differences in expression between control bearing only pHA-Ybx1 and cotransfectants. Statistical analysis of the data was performed by Student's t-test using GraphPad Prism; \*p≤0.05.](pone.0199472.g007){#pone.0199472.g007}

![Validation of HMGB1 and BHMT interaction.\
Cos7 cells were transfected with pFLAG-BHMT, pHA-HMGB1 or cotransfected with both plasmids at a 1:1 (w/w) ratio. Lysates were obtained 48 hours posttransfection and immediately processed by anti-FLAG immunoprecipitation. Input (25 μl) and immunoprecipitate samples (40 μl) were analyzed by western blotting using specific antibodies and mouse TrueBlot. (A) Representative anti-HA immunoblots of the experiments performed (N = 3). (B) Representative anti-FLAG images of the experiments carried out (N = 3). The size of the protein standards is indicated on the left side of each image.](pone.0199472.g008){#pone.0199472.g008}

![Coimmunoprecipitation of Prkaca and BHMT.\
Cos7 cells were transfected with pFLAG-BHMT, pHA-Prkaca or cotransfected with both plasmids at a 1:1 (w/w) ratio. Lysates were obtained 48 hours posttransfection and immediately processed by anti-FLAG immunoprecipitation. Input (25 μl) and immunoprecipitate samples (40 μl) were analyzed by western blotting mouse primary antibodies and mouse TrueBlot. (A) Representative anti-HA immunoblot of the immunoprecipitation experiments performed (N = 3). (B) Representative images of anti-FLAG immunoblots of the experiments carried out (N = 3). The size of the protein standards is indicated at the left side of each image. (C) Anti-HA signals were quantified from all experiments (N = 3) using ImageJ and the immunoprecipitate/input ratio (mean ± SEM) calculated to correct for differences in expression between control bearing only pHA-Prkaca and cotransfectants. Statistical analysis of the data was performed by Student's t-test using GraphPad Prism; \*p≤0.05.](pone.0199472.g009){#pone.0199472.g009}

We also sought out for validation of putative preys found in the YTH screening that were detected in previous AP-MS experiments, but that showed unspecific binding to chitin columns. This is the case of ALDOB and HPD. For this purpose, cotransfection with pFLAG-BHMT and pHA-ALDOB or pHA-HPD was performed and anti-HA immunoprecipitation carried out ([Fig 10](#pone.0199472.g010){ref-type="fig"}). In both cases, anti-BHMT recognized a band immediately below the heavy chain of anti-HA in the immunoprecipitates of cotransfected cells. Thus, ALDOB and HPD were confirmed as BHMT interaction targets.

![Confirmation of the BHMT/ALDOB and BHMT/HPD interaction.\
Cos7 cells were transfected with pFLAG-BHMT, pHA-ALDOB and pHA-HPD or cotransfected with pFLAG-BHMT and either of the pHA-preys at a 1:1 (w/w) ratio. Lysates were obtained 48 hours posttransfection and immediately processed by immunoprecipitation. Samples (30 μl) of the inputs and anti-HA immunoprecipitates were loaded on 14% SDS-PAGE gels and analyzed by western blotting. (A) Representative immunoblot of the immunoprecipitation experiments (N = 4) performed for ALDOB analyzed with a mixture of anti-HA and anti-BHMT. (B) Representative immunoblot of the immunoprecipitation experiments (N = 4) performed for HPD analyzed with a mixture of anti-HA and anti-BHMT. The size of the protein standards is indicated on the side of each image. (\*) Specific BHMT, ALDOB and HPD bands are indicated in the immunoprecipitation lanes.](pone.0199472.g010){#pone.0199472.g010}

Finally, protein-protein interaction network analysis was carried out for the whole set of BHMT interaction targets identified by AP-MS and YTH using STRING. The PPI network constructed contained 131 proteins, 122 nodes and 165 edges ([Fig 11A](#pone.0199472.g011){ref-type="fig"}). The average node degree was 2.7 and the PPI enrichment value 4.81e-05. This tool classified the targets in a large number of pathways with statistical significance (FDR \<0.05). Several GO pathways were found and grouped according to the biological process (152; [Table 6](#pone.0199472.t006){ref-type="table"}), the molecular function (48; [Table 7](#pone.0199472.t007){ref-type="table"}) and the cellular component (58; [Table 8](#pone.0199472.t008){ref-type="table"}). Moreover, a limited number of KEGG pathways (4) with FDR \<0.05 were also identified, including the biosynthesis of amino acids (ID 01230; 4.63e-05), cysteine and methionine metabolism (ID 00270; 0.000212), the spliceosome (ID 03040; 0.000408) and metabolic pathways (ID 01100; 0.04) ([Fig 11B](#pone.0199472.g011){ref-type="fig"}). Some of these pathways were also recognized when analysis of the interaction targets was performed with Bioprofiling, although the set with statistical significance was more limited.

![Network analysis using STRING and new validated interaction targets.\
The whole set of BHMT interaction targets identified by affinity purification/mass spectrometry and yeast two-hybrid was analyzed using STRING set at medium confidence 0.4. (A) The panel shows the network links. (B) Pie chart illustrating the distribution between KEGG pathways with false discovery rates \<0.05; The number of proteins identified for each pathway is indicated in parenthesis. (C) Schematic representation of the validated BHMT interactions identified in the present study. Abbreviations: BHMT, betaine homocysteine S-methyltransferase; BHMT2, S-methylmethionine methyltransferase or betaine homocysteine methyltransferase 2; MATα1, methionine adenosyltransferase alpha1; MATα2, methionine adenosyltransferase alpha2; MATβ, methionine adenosyltransferase beta; ALDOB, aldolase b; Prkaca, cAMP-dependent protein kinase catalytic subunit alpha; HPD, 4-hydroxyphenylpyruvic acid dioxygenase.](pone.0199472.g011){#pone.0199472.g011}

10.1371/journal.pone.0199472.t006

###### STRING classification of BHMT interaction targets according to the biological process (GO).

![](pone.0199472.t006){#pone.0199472.t006g}

  pathway ID   pathway description                                                       count in protein set   false discovery rate
  ------------ ------------------------------------------------------------------------- ---------------------- ----------------------
  GO:0008152   metabolic process                                                         65                     1.57e-18
  GO:0044237   cellular metabolic process                                                60                     1.57e-18
  GO:0044238   primary metabolic process                                                 59                     1.13e-17
  GO:0071704   organic substance metabolic process                                       60                     1.13e-17
  GO:0009987   cellular process                                                          72                     2.04e-17
  GO:0006807   nitrogen compound metabolic process                                       45                     1.32e-16
  GO:0034641   cellular nitrogen compound metabolic process                              42                     1.86e-15
  GO:0008150   biological_process                                                        66                     2.88e-12
  GO:1901360   organic cyclic compound metabolic process                                 36                     1.36e-11
  GO:0044260   cellular macromolecule metabolic process                                  42                     1.48e-11
  GO:0006725   cellular aromatic compound metabolic process                              34                     6.32e-11
  GO:0043170   macromolecule metabolic process                                           43                     1.06e-10
  GO:0046483   heterocycle metabolic process                                             33                     1.94e-10
  GO:0006139   nucleobase-containing compound metabolic process                          32                     2.02e-10
  GO:0044699   single-organism process                                                   54                     3.76e-08
  GO:0044271   cellular nitrogen compound biosynthetic process                           26                     5.02e-08
  GO:0010467   gene expression                                                           26                     2.3e-07
  GO:0009058   biosynthetic process                                                      30                     3.64e-07
  GO:0044249   cellular biosynthetic process                                             29                     4e-07
  GO:0050896   response to stimulus                                                      40                     4e-07
  GO:0044763   single-organism cellular process                                          49                     6.11e-07
  GO:1901576   organic substance biosynthetic process                                    29                     8.02e-07
  GO:0090304   nucleic acid metabolic process                                            24                     1.39e-06
  GO:0006575   cellular modified amino acid metabolic process                            9                      1.52e-06
  GO:0006396   RNA processing                                                            12                     2.32e-06
  GO:1901564   organonitrogen compound metabolic process                                 19                     2.34e-06
  GO:0006397   mRNA processing                                                           10                     2.89e-06
  GO:0042221   response to chemical                                                      29                     3.4e-06
  GO:0008380   RNA splicing                                                              9                      5.87e-06
  GO:0051252   regulation of RNA metabolic process                                       21                     8.69e-06
  GO:0031323   regulation of cellular metabolic process                                  29                     1.29e-05
  GO:0044281   small molecule metabolic process                                          19                     1.41e-05
  GO:0060255   regulation of macromolecule metabolic process                             28                     1.51e-05
  GO:0044767   single-organism developmental process                                     31                     1.52e-05
  GO:0019219   regulation of nucleobase-containing compound metabolic process            22                     2.16e-05
  GO:0080090   regulation of primary metabolic process                                   28                     2.16e-05
  GO:0051171   regulation of nitrogen compound metabolic process                         23                     2.51e-05
  GO:0048856   anatomical structure development                                          28                     3.69e-05
  GO:0016070   RNA metabolic process                                                     20                     3.86e-05
  GO:0044710   single-organism metabolic process                                         27                     3.86e-05
  GO:0006556   S-adenosylmethionine biosynthetic process                                 3                      3.89e-05
  GO:0019222   regulation of metabolic process                                           30                     4.05e-05
  GO:0065007   biological regulation                                                     41                     4.4e-05
  GO:0048519   negative regulation of biological process                                 26                     4.92e-05
  GO:0050794   regulation of cellular process                                            38                     7.24e-05
  GO:0044267   cellular protein metabolic process                                        22                     7.34e-05
  GO:0051716   cellular response to stimulus                                             30                     8.03e-05
  GO:0048523   negative regulation of cellular process                                   24                     0.000104
  GO:0034654   nucleobase-containing compound biosynthetic process                       18                     0.000117
  GO:0010468   regulation of gene expression                                             21                     0.000126
  GO:0010033   response to organic substance                                             23                     0.000134
  GO:2000112   regulation of cellular macromolecule biosynthetic process                 20                     0.000157
  GO:0070887   cellular response to chemical stimulus                                    19                     0.000164
  GO:0050789   regulation of biological process                                          38                     0.000191
  GO:0007275   multicellular organismal development                                      26                     0.00031
  GO:0048731   system development                                                        24                     0.000343
  GO:0019538   protein metabolic process                                                 23                     0.000393
  GO:0044272   sulfur compound biosynthetic process                                      5                      0.000456
  GO:1901566   organonitrogen compound biosynthetic process                              12                     0.00052
  GO:0034645   cellular macromolecule biosynthetic process                               19                     0.000618
  GO:0048522   positive regulation of cellular process                                   24                     0.000655
  GO:0071310   cellular response to organic substance                                    16                     0.000737
  GO:1901699   cellular response to nitrogen compound                                    10                     0.000862
  GO:0006355   regulation of transcription, DNA-templated                                17                     0.00102
  GO:0045934   negative regulation of nucleobase-containing compound metabolic process   11                     0.0014
  GO:1901698   response to nitrogen compound                                             14                     0.00152
  GO:0032501   multicellular organismal process                                          28                     0.00209
  GO:0001889   liver development                                                         6                      0.00211
  GO:0030334   regulation of cell migration                                              9                      0.00211
  GO:0061008   hepaticobiliary system development                                        6                      0.00211
  GO:0051253   negative regulation of RNA metabolic process                              10                     0.00219
  GO:0042398   cellular modified amino acid biosynthetic process                         4                      0.00224
  GO:0006403   RNA localization                                                          5                      0.0023
  GO:0010608   posttranscriptional regulation of gene expression                         7                      0.0025
  GO:0042981   regulation of apoptotic process                                           13                     0.0025
  GO:0009719   response to endogenous stimulus                                           17                     0.00251
  GO:0009056   catabolic process                                                         14                     0.00253
  GO:0071417   cellular response to organonitrogen compound                              9                      0.00259
  GO:0048513   organ development                                                         18                     0.0026
  GO:0010629   negative regulation of gene expression                                    11                     0.00291
  GO:0033528   S-methylmethionine cycle                                                  2                      0.00326
  GO:0042450   arginine biosynthetic process via ornithine                               2                      0.00326
  GO:0042493   response to drug                                                          11                     0.00326
  GO:0019752   carboxylic acid metabolic process                                         11                     0.00329
  GO:0010243   response to organonitrogen compound                                       13                     0.00338
  GO:1901701   cellular response to oxygen-containing compound                           11                     0.00364
  GO:2000113   negative regulation of cellular macromolecule biosynthetic process        10                     0.00367
  GO:0072521   purine-containing compound metabolic process                              7                      0.00393
  GO:0043412   macromolecule modification                                                16                     0.00406
  GO:0048518   positive regulation of biological process                                 24                     0.00406
  GO:0010605   negative regulation of macromolecule metabolic process                    14                     0.00408
  GO:0080134   regulation of response to stress                                          10                     0.00442
  GO:0014070   response to organic cyclic compound                                       14                     0.0045
  GO:0055086   nucleobase-containing small molecule metabolic process                    8                      0.005
  GO:0009605   response to external stimulus                                             15                     0.0051
  GO:0046683   response to organophosphorus                                              6                      0.00524
  GO:0044707   single-multicellular organism process                                     26                     0.00548
  GO:0044248   cellular catabolic process                                                12                     0.00562
  GO:1901575   organic substance catabolic process                                       12                     0.00567
  GO:0006950   response to stress                                                        19                     0.00599
  GO:0055114   oxidation-reduction process                                               11                     0.00649
  GO:0035556   intracellular signal transduction                                         12                     0.00651
  GO:1903311   regulation of mRNA metabolic process                                      4                      0.00665
  GO:0006464   cellular protein modification process                                     15                     0.00674
  GO:0032879   regulation of localization                                                17                     0.00674
  GO:1903312   negative regulation of mRNA metabolic process                             3                      0.0069
  GO:1990267   response to transition metal nanoparticle                                 6                      0.00723
  GO:0006796   phosphate-containing compound metabolic process                           14                     0.0073
  GO:0006351   transcription, DNA-templated                                              13                     0.0085
  GO:0006810   transport                                                                 21                     0.00895
  GO:0007399   nervous system development                                                15                     0.00983
  GO:1901700   response to oxygen-containing compound                                    15                     0.00988
  GO:0014074   response to purine-containing compound                                    6                      0.0103
  GO:0071345   cellular response to cytokine stimulus                                    7                      0.0105
  GO:0006730   one-carbon metabolic process                                              3                      0.0106
  GO:0043488   regulation of mRNA stability                                              3                      0.0106
  GO:0009725   response to hormone                                                       13                     0.011
  GO:0010038   response to metal ion                                                     8                      0.0115
  GO:0071495   cellular response to endogenous stimulus                                  11                     0.0115
  GO:0009066   aspartate family amino acid metabolic process                             3                      0.012
  GO:0043604   amide biosynthetic process                                                7                      0.0121
  GO:0045787   positive regulation of cell cycle                                         5                      0.0123
  GO:0071786   endoplasmic reticulum tubular network organization                        2                      0.0125
  GO:0031324   negative regulation of cellular metabolic process                         13                     0.0134
  GO:0034097   response to cytokine                                                      8                      0.0135
  GO:1903034   regulation of response to wounding                                        6                      0.0135
  GO:0048583   regulation of response to stimulus                                        16                     0.0151
  GO:0051260   protein homooligomerization                                               6                      0.0167
  GO:0071375   cellular response to peptide hormone stimulus                             6                      0.0177
  GO:0043434   response to peptide hormone                                               8                      0.0183
  GO:0010035   response to inorganic substance                                           9                      0.0191
  GO:0032069   regulation of nuclease activity                                           2                      0.0191
  GO:0050658   RNA transport                                                             4                      0.0191
  GO:0023051   regulation of signaling                                                   15                     0.0206
  GO:0045892   negative regulation of transcription, DNA-templated                       8                      0.0211
  GO:0051726   regulation of cell cycle                                                  8                      0.0211
  GO:0010646   regulation of cell communication                                          15                     0.0227
  GO:0046128   purine ribonucleoside metabolic process                                   5                      0.0236
  GO:1901605   alpha-amino acid metabolic process                                        5                      0.0244
  GO:0051179   localization                                                              22                     0.0272
  GO:0044711   single-organism biosynthetic process                                      10                     0.0286
  GO:0065003   macromolecular complex assembly                                           10                     0.0314
  GO:0071840   cellular component organization or biogenesis                             20                     0.0319
  GO:0051259   protein oligomerization                                                   7                      0.032
  GO:0000050   urea cycle                                                                2                      0.0351
  GO:0071316   cellular response to nicotine                                             2                      0.0351
  GO:1901135   carbohydrate derivative metabolic process                                 8                      0.0368
  GO:0006417   regulation of translation                                                 5                      0.0369
  GO:0032414   positive regulation of ion transmembrane transporter activity             3                      0.0386
  GO:0006461   protein complex assembly                                                  9                      0.0403
  GO:0070271   protein complex biogenesis                                                9                      0.0403
  GO:0071407   cellular response to organic cyclic compound                              7                      0.0426

10.1371/journal.pone.0199472.t007

###### STRING classification of BHMT interaction targets according to molecular function (GO).
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  pathway ID   pathway description                                              count in protein set   false discovery rate
  ------------ ---------------------------------------------------------------- ---------------------- ----------------------
  GO:1901363   heterocyclic compound binding                                    47                     1.69e-15
  GO:0097159   organic cyclic compound binding                                  47                     1.71e-15
  GO:0003674   molecular_function                                               69                     4.1e-14
  GO:0005488   binding                                                          59                     8.46e-12
  GO:0003723   RNA binding                                                      22                     9.75e-12
  GO:0043167   ion binding                                                      44                     1.15e-10
  GO:0003676   nucleic acid binding                                             28                     2.69e-10
  GO:0000166   nucleotide binding                                               29                     3.54e-10
  GO:0036094   small molecule binding                                           31                     3.54e-10
  GO:0003697   single-stranded DNA binding                                      7                      3.31e-08
  GO:0043168   anion binding                                                    28                     7.59e-08
  GO:0008134   transcription factor binding                                     10                     5.78e-07
  GO:0005515   protein binding                                                  32                     1.27e-06
  GO:0032550   purine ribonucleoside binding                                    20                     8.44e-06
  GO:0035639   purine ribonucleoside triphosphate binding                       20                     8.44e-06
  GO:0097367   carbohydrate derivative binding                                  22                     8.44e-06
  GO:0003824   catalytic activity                                               34                     1.04e-05
  GO:0032555   purine ribonucleotide binding                                    20                     1.04e-05
  GO:0043566   structure-specific DNA binding                                   8                      1.64e-05
  GO:0005524   ATP binding                                                      17                     2.62e-05
  GO:0044822   poly(A) RNA binding                                              11                     4.59e-05
  GO:0003677   DNA binding                                                      15                     5.7e-05
  GO:0019899   enzyme binding                                                   14                     7.11e-05
  GO:0043169   cation binding                                                   25                     0.000118
  GO:0046872   metal ion binding                                                24                     0.000199
  GO:0008289   lipid binding                                                    10                     0.00102
  GO:0016491   oxidoreductase activity                                          11                     0.00126
  GO:0016829   lyase activity                                                   6                      0.00147
  GO:0005198   structural molecule activity                                     9                      0.00152
  GO:0043021   ribonucleoprotein complex binding                                4                      0.00188
  GO:0004478   methionine adenosyltransferase activity                          2                      0.00229
  GO:0044877   macromolecular complex binding                                   12                     0.00229
  GO:0047150   betaine-homocysteine S-methyltransferase activity                2                      0.00229
  GO:0008898   S-adenosylmethionine-homocysteine S-methyltransferase activity   2                      0.00667
  GO:0051082   unfolded protein binding                                         3                      0.00877
  GO:0097100   supercoiled DNA binding                                          2                      0.0124
  GO:0003729   mRNA binding                                                     4                      0.0132
  GO:0016740   transferase activity                                             14                     0.0174
  GO:0042162   telomeric DNA binding                                            2                      0.0193
  GO:0016860   intramolecular oxidoreductase activity                           3                      0.0266
  GO:0008301   DNA binding, bending                                             2                      0.0379
  GO:0016840   carbon-nitrogen lyase activity                                   2                      0.0379
  GO:0043565   sequence-specific DNA binding                                    7                      0.0385
  GO:0019901   protein kinase binding                                           6                      0.0415
  GO:0051059   NF-kappaB binding                                                2                      0.0476
  GO:0004672   protein kinase activity                                          7                      0.0491
  GO:0004674   protein serine/threonine kinase activity                         6                      0.0495
  GO:0019843   rRNA binding                                                     3                      0.0497

10.1371/journal.pone.0199472.t008

###### STRING classification of BHMT interaction targets according to the cellular component (GO).

![](pone.0199472.t008){#pone.0199472.t008g}

  Cellular component (GO)                                                                        
  ------------------------- --------------------------------------------------------------- ---- ----------
  GO:0044424                intracellular part                                              76   2.91e-20
  GO:0005622                intracellular                                                   76   5.88e-20
  GO:0005737                cytoplasm                                                       69   1.93e-17
  GO:0044464                cell part                                                       76   1.93e-17
  GO:0005623                cell                                                            76   1.94e-17
  GO:0005634                nucleus                                                         46   5.75e-15
  GO:0005575                cellular_component                                              74   2.38e-14
  GO:0043226                organelle                                                       63   2.38e-14
  GO:0044446                intracellular organelle part                                    50   3.06e-14
  GO:0032991                macromolecular complex                                          41   2.36e-13
  GO:0043229                intracellular organelle                                         60   4.26e-13
  GO:0043227                membrane-bounded organelle                                      58   1.01e-12
  GO:0043231                intracellular membrane-bounded organelle                        55   1.42e-11
  GO:0044428                nuclear part                                                    26   1.4e-09
  GO:0070013                intracellular organelle lumen                                   26   2.16e-09
  GO:0044444                cytoplasmic part                                                46   2.18e-09
  GO:0030529                ribonucleoprotein complex                                       15   4.57e-09
  GO:0043232                intracellular non-membrane-bounded organelle                    29   4.57e-09
  GO:0031981                nuclear lumen                                                   22   3.42e-08
  GO:0048471                perinuclear region of cytoplasm                                 13   4.19e-06
  GO:0070062                extracellular exosome                                           18   7.02e-06
  GO:0005829                cytosol                                                         20   9.86e-06
  GO:0031988                membrane-bounded vesicle                                        22   1.03e-05
  GO:0043234                protein complex                                                 26   1.51e-05
  GO:0044421                extracellular region part                                       22   1.51e-05
  GO:0031982                vesicle                                                         22   2.21e-05
  GO:0016020                membrane                                                        41   2.31e-05
  GO:0005681                spliceosomal complex                                            6    3.33e-05
  GO:0005654                nucleoplasm                                                     15   3.77e-05
  GO:0005576                extracellular region                                            23   0.00014
  GO:0005739                mitochondrion                                                   15   0.000765
  GO:0000793                condensed chromosome                                            5    0.000945
  GO:0048269                methionine adenosyltransferase complex                          2    0.000945
  GO:0098588                bounding membrane of organelle                                  17   0.000945
  GO:0031090                organelle membrane                                              20   0.000973
  GO:0005793                endoplasmic reticulum-Golgi intermediate compartment            4    0.00136
  GO:0012505                endomembrane system                                             21   0.00281
  GO:0005730                nucleolus                                                       8    0.00313
  GO:0005783                endoplasmic reticulum                                           13   0.00434
  GO:1990124                messenger ribonucleoprotein complex                             2    0.00474
  GO:0005694                chromosome                                                      7    0.00912
  GO:0043209                myelin sheath                                                   5    0.00912
  GO:0005856                cytoskeleton                                                    12   0.0138
  GO:0042470                melanosome                                                      4    0.0138
  GO:0016607                nuclear speck                                                   4    0.0146
  GO:0034663                endoplasmic reticulum chaperone complex                         2    0.0146
  GO:0042175                nuclear outer membrane-endoplasmic reticulum membrane network   9    0.0183
  GO:0005886                plasma membrane                                                 22   0.0188
  GO:0044451                nucleoplasm part                                                6    0.0225
  GO:0000777                condensed chromosome kinetochore                                3    0.0226
  GO:0070852                cell body fiber                                                 2    0.0226
  GO:0071944                cell periphery                                                  22   0.0237
  GO:0044427                chromosomal part                                                6    0.0261
  GO:0044432                endoplasmic reticulum part                                      9    0.0272
  GO:0000779                condensed chromosome, centromeric region                        3    0.0328
  GO:0042995                cell projection                                                 14   0.0332
  GO:0044430                cytoskeletal part                                               9    0.0447
  GO:0044431                Golgi apparatus part                                            7    0.0499

Discussion {#sec014}
==========

The association of hyperhomocysteinemia (HHcy) with a large variety of diseases has increased the interest in the regulation of enzymes involved in Hcy metabolism and, among them BHMT. Knowledge about this protein and its regulation was hampered by a number difficulties since its discovery approximately 70 years ago (reviewed in \[[@pone.0199472.ref006]\]). Nevertheless, the last decades have seen a notable increase in data regarding the role of BHMT in disease. Several high throughput studies have provided information concerning PTMs occurring on BHMT or its putative interaction partners in human, rat and mouse \[[@pone.0199472.ref026]--[@pone.0199472.ref036], [@pone.0199472.ref049]\]. These targets are expected to be conserved among species given the high level of sequence identity (\>90%) shown by BHMTs. However, the major drawback of these studies relies on the fact that only a few of them have gone further to confirm the interactions detected using additional techniques.

BHMT interaction targets listed in the IntAct and BioGRID databases, as well as in the literature include approximately 22 interaction partners ([Table 9](#pone.0199472.t009){ref-type="table"}) \[[@pone.0199472.ref012], [@pone.0199472.ref033]--[@pone.0199472.ref036], [@pone.0199472.ref050]--[@pone.0199472.ref057]\]. However, only seven of these targets have been also identified in our study. Moreover, our results rise doubts about the validity of several BHMT interaction partners included in this list, as tubulin, 10-formyltetrahydrofolate dehydrogenase (Aldh1l1) and carbamoyl phosphate synthetase 1 show unspecific binding to chitin and chitin-intein columns, and no interaction with chitin-intein-BHMT beads. Therefore, among the previously reported BHMT interaction targets only 14-3-3 protein epsilon (Ywhae), tissue-type transglutaminase \[[@pone.0199472.ref033], [@pone.0199472.ref051]\], HMGB1 \[[@pone.0199472.ref036]\], and BHMT2 \[[@pone.0199472.ref034], [@pone.0199472.ref035]\] bind to BHMT columns in our study. These interactions exhibit different characteristics. For example, the Ywhae-BHMT interaction is lost in the presence of low salt concentrations, whereas the BHMT2-BHMT interaction remains stable. Furthermore, the Ywhae-BHMT interaction is detected only in one of our AP-MS experiments, suggesting that the interaction might be very weak or take place only under specific conditions.

10.1371/journal.pone.0199472.t009

###### Interactions reported for BHMT in human, rat or mouse.

![](pone.0199472.t009){#pone.0199472.t009g}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  target                                                                       Uniprot code   method                                                                                                                                                     organism                 reference
  ---------------------------------------------------------------------------- -------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------ ----------------------------------------------------
  ApoB mRNA editing                                                                           Screening of liver cDNA expression library                                                                                                                 rat                      \[[@pone.0199472.ref012]\]

  Myotubularin-related protein 6 (MTMR6)                                       Q9Y217         Affinity purification and MS[^a^](#t009fn001){ref-type="table-fn"}                                                                                         human                    \[[@pone.0199472.ref035]\]

  High mobility group protein B1 (HMGB1)                                       P63159         Ischemia/reperfusion, liver IP[^b^](#t009fn002){ref-type="table-fn"}, 2D[^c^](#t009fn003){ref-type="table-fn"}, MS[^a^](#t009fn001){ref-type="table-fn"}   rat                      \[[@pone.0199472.ref036]\]

  Tubulin                                                                      P68370         Liver purification, SDS-PAGE and MS[^a^](#t009fn001){ref-type="table-fn"}                                                                                  rat                      \[[@pone.0199472.ref050]\]

  Tissue-type transglutaminase                                                 Q9WVJ6         *In vitro* modification and MS[^a^](#t009fn001){ref-type="table-fn"}                                                                                       mouse, guinea pig, rat   \[[@pone.0199472.ref033], [@pone.0199472.ref051]\]

  S-protein of HBV                                                                            YTH[^d^](#t009fn004){ref-type="table-fn"} (liver library)                                                                                                  human                    \[[@pone.0199472.ref052]\]

  Glucocortocoid receptor (Nr3c1)                                              P06536         Liver immunoaffinity chromatography, 2D[^c^](#t009fn003){ref-type="table-fn"}, MS[^a^](#t009fn001){ref-type="table-fn"}                                    rat                      \[[@pone.0199472.ref053]\]

  10-formyltetrahydrofolate dehydrogenase + carbamoyl phosphate synthetase 1   P28037\        Liver affinity purification and N-terminal sequencing                                                                                                      rat                      \[[@pone.0199472.ref054]\]
                                                                               P07756                                                                                                                                                                                             

  Bardet-Biedl syndrome 1 protein (BBS1)                                       Q8NFJ9         YTH[^d^](#t009fn004){ref-type="table-fn"} (fetal kidney library)                                                                                           human                    \[[@pone.0199472.ref055]\]

  Bardet-Biedl syndrome 2 protein (BBS2)                                       Q9BXC9         YTH[^d^](#t009fn004){ref-type="table-fn"} (fetal kidney library)                                                                                           human                    \[[@pone.0199472.ref055]\]

  Bardet-Biedl syndrome 4 protein (BBS4)                                       Q96RK4         YTH[^d^](#t009fn004){ref-type="table-fn"} (fetal kidney library)                                                                                           human                    \[[@pone.0199472.ref055]\]

  Regulator complex protein LAMTOR3/ MAPKSP1                                   Q9UHA4         YTH[^d^](#t009fn004){ref-type="table-fn"} (adult liver library)                                                                                            human                    \[[@pone.0199472.ref056]\]

  Alpha-1,2-mannosyltransferase ALG9                                           Q9H6U8         YTH[^d^](#t009fn004){ref-type="table-fn"} (adult liver library)                                                                                            human                    \[[@pone.0199472.ref056]\]

  X antigen binding protein 1 of HBV/LAMTOR5                                   O43504         YTH[^d^](#t009fn004){ref-type="table-fn"} (cDNA liver library)                                                                                             human                    \[[@pone.0199472.ref057]\]

  S-methylmethionine homocysteine S-methyltransferase BHMT2                    Q9H2M3         Affinity purification and MS[^a^](#t009fn001){ref-type="table-fn"}                                                                                         human                    \[[@pone.0199472.ref034], [@pone.0199472.ref035]\]

  E3 ubiquitin-protein ligase ZNRF1                                            Q8ND25         Affinity purification and MS[^a^](#t009fn001){ref-type="table-fn"}                                                                                         human                    \[[@pone.0199472.ref034]\]

  Melanoregulain (MREG)                                                        Q8N565         Affinity purification and MS[^a^](#t009fn001){ref-type="table-fn"}                                                                                         human                    \[[@pone.0199472.ref034]\]

  Aldehyde dehydrogenase family 16 member A1 (Aldh16a1)                        Q3T1L0         Blue native gels                                                                                                                                           rat                      IntAct

  14-3-3 protein epsilon (Ywhae)                                               P62259         cosedimentation                                                                                                                                            mouse                    IntAct

  6-phosphoglucono lactone (Pgls)                                              Q9CQ60         cosedimentation                                                                                                                                            mouse                    IntAct

  3 beta-hydroxysteroid dehydrogenase type 7 (Hsd3b7)                          Q9EQC1         cosedimentation                                                                                                                                            mouse                    IntAct
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^MS, mass spectrometry

^b^IP, immunoprecipitation

^c^2D, two-dimensional electrophoresis

^d^YTH, yeast two-hybrid

Regarding tissue-type transglutaminase, its interaction with BHMT was expected, since previous studies showed the ability of this enzyme to modify BHMT on a single peptide \[[@pone.0199472.ref033], [@pone.0199472.ref051]\]. This peptide contains four glutamine residues that can be transglutaminated by their crosslinking with lysine residues of other proteins or with free amines. Different degrees of modification can be detected in this peptide, but in all the cases transglutamination reduces BHMT activity \[[@pone.0199472.ref051]\].

The BHMT interaction with HMGB1 requires translocation of the latter from the nucleus to the cytoplasm, as demonstrated by coimmunoprecipitation from selective hepatic ischemia/reperfusion samples \[[@pone.0199472.ref036]\]. However, a small amount of HMGB1 seems to exist in the cytoplasm of control liver samples, as shown in the corresponding coimmunoprecipitates. Our AP-MS study confirms the existence of the HMGB1-BHMT interaction in normal liver, but no coimmunoprecipitation is detected in validation experiments. This opposite behavior could be explained by differences in the cytosolic samples used for coimmunoprecipitation experiments by both groups and may regard on disparities in the content or the presence/loss of specific PTMs in HMGB1. Precisely, Zhang et al. used control liver lobes obtained during a selective ischemia/reperfusion procedure to prepare their cytosolic samples \[[@pone.0199472.ref036]\], whereas our validation experiments were carried out with cytosol from cotransfected cell lines.

The BHMT-BHMT2 interaction was previously detected in two AP-MS high-throughput studies carried out with human samples \[[@pone.0199472.ref034], [@pone.0199472.ref035]\], and we found this interaction both in our AP-MS and YTH experiments. Thus, the validity of this interaction was confirmed. Moreover, our data indicate that this interaction is strong and/or favored in the presence of salt, since excision of the intein tag is required for BHMT2 elution from the chitin-intein-BHMT column. This fact could be expected from the high percentage of identity between both proteins (73%) and their similar structural features, with the exception of the C-terminal α-helix \[[@pone.0199472.ref058], [@pone.0199472.ref059]\]. Lack of this α-helix results in a reduced stability of the BHMT2 oligomer \[[@pone.0199472.ref024], [@pone.0199472.ref059]\], and hence under certain circumstances a heterotetrameric BHMT-BHMT2 association could be an advantage. Both proteins, BHMT and BHMT2 belong to the methionine cycle and, in their tetrameric form, catalyze the methylation of Hcy for the synthesis of methionine using different methyl donors \[[@pone.0199472.ref060]\]. While BHMT utilizes betaine for the synthesis of one molecule of methionine, BHMT2 uses S-methylmethionine to produce two molecules of this amino acid \[[@pone.0199472.ref006]\]. Therefore, a BHMT-BHMT2 heterotetramer may provide additional stability to BHMT2 that putatively results in an increased production of methionine.

Data of our AP-MS study further expand this BHMT interaction network including 128 new putative interaction partners, some of which have been validated by coimmunoprecipitation. Interestingly, two of the validated interaction targets are the catalytic subunits of methionine adenosyltransferases MATα1 and MATα2, which also belong to the methionine cycle. The function of these proteins also depends on their oligomerization that occurs into homodimers and homotetramers for MATα1 or homotetramers and heterotrimers for MATα2 \[[@pone.0199472.ref038], [@pone.0199472.ref061]--[@pone.0199472.ref063]\]. The resulting isoenzymes require a constant methionine supply for the synthesis of the main cellular methyl donor, S-adenosylmethionine \[[@pone.0199472.ref064]\]. If methionine levels are reduced, the need of this essential amino acid could be supported by Hcy recycling through methylation \[[@pone.0199472.ref006], [@pone.0199472.ref064]\]. It is under these circumstances when the interaction between BHMT and MATs could improve S-adenosylmethionine synthesis to sustain the large variety of reactions that depend on this key metabolite.

Another validated BHMT interaction target is Prkaca, the cAMP-dependent protein kinase catalytic subunit alpha, which phosphorylates a large number of substrates and is involved in key regulatory mechanisms \[[@pone.0199472.ref065]\]. Several high-throughput studies have analyzed the human, mouse and rat phosphoproteome and the results obtained indicate that BHMTs of these organisms can be phosphorylated on several residues \[[@pone.0199472.ref026], [@pone.0199472.ref049], [@pone.0199472.ref066]--[@pone.0199472.ref068]\]. Among them, some serine residues are predicted as putative targets for PKA phosphorylation by KinasePhos (S^330^ and S^368^) and NetPhos 3.1 (S^68^, S^222^, S^245^ and S^405^). Nevertheless, effects derived from BHMT phosphorylation have not been further explored, despite their putative involvement in the control of enzyme activity and/or association events. Additionally, phosphorylation could be implicated in the nucleocytoplasmic shuttling of BHMT, an event that to date has been only linked to changes in the GSH/GSSG ratio that occur in acute liver injury \[[@pone.0199472.ref011]\]. Combination of different PTMs, their sequential or independent incorporation may regulate binding to importin or exportin carriers and, in turn, the changes in subcellular distribution.

Additional BHMT interaction targets identified and validated in our study are ALDOB and HPD. The former is a glycolytic enzyme that synthesizes glyceraldehyde 3-phosphate from fructose 1,6-bisphosphate \[[@pone.0199472.ref069]\], whereas the latter is a key enzyme in phenylalanine and tyrosine degradation that converts 4-hydroxyphenylpyruvate in homogentisate \[[@pone.0199472.ref070]\]. Although no obvious link between these enzymes and BHMT is known, it is interesting to recall that fumaryl acetoacetate, a downstream metabolite of homogentisate, is an inhibitor of MAT \[[@pone.0199472.ref071]\]. Hence, interaction of HPD and BHMT may result in a crosstalk between both pathways in order to control methionine levels, which may otherwise increase in parallel with fumaryl acetoacetate concentrations as observed in tyrosinemia type I \[[@pone.0199472.ref072]\]. Indirect links between ALDOB and BHMT could derive from the following facts: i) NADP^+^ production in the polyol pathway controls S-adenosylmethionine synthesis through MAT II hetero-oligomerization, in turn, reducing methionine pools; ii) elimination of fructose, the final product of the polyol pathway, involves ALDOB; iii) among the downstream metabolites generated during fructose metabolism is acyl-glycerol, which joins apolipoproteins to form lipoproteins; and iv) apoB mRNA levels correlate with BHMT protein levels and increase when the latter is induced \[[@pone.0199472.ref012], [@pone.0199472.ref073]\]. Nevertheless, this putative crossregulation needs to be further explored.

A recent integration of over 9000 MS experiments in order to build a global map of human protein complexes, the hu.MAP \[[@pone.0199472.ref074]\], has shown BHMT only in two complexes. Complex number 25 comprises BHMT and BHMT2, whereas complex number 2283 contains BHMT, BHMT2 and tubulin-specific chaperone E (TBCE). The scores calculated for the complexes TBCE-BHMT2 (0.9388) and TBCE-BHMT (0.0953) yet suggest that binding to the chaperone occurs indirectly through BHMT2. These results are in accordance with our present study, where the BHMT-BHMT2 interaction is detected by AP-MS and YTH. Moreover, no BHMT-tubulin interaction is identified, further confirming the lack of specific binding observed in our AP-MS experiments, despite the previous proposal of BHMT coassembly with tubulin dimers into microtubules \[[@pone.0199472.ref050]\]. These differences may rely on the use of normal or taxol-treated rat liver samples and from the different techniques utilized in both studies, AP-MS or cosedimentation.

Network analysis shows three highly connected subnetworks within the whole dataset identified by AP-MS and YTH ([Fig 11A](#pone.0199472.g011){ref-type="fig"}). One of these groups comprises targets of the methionine cycle, a second is established around ACTB on one side and the ribosomal Fau protein on the other, and a third is centered around heterogeneous nuclear ribonucleoproteins (Hnrnp). Direct interactions of BHMT are only shown for partners within the methionine cycle and L-serine dehydratase/L-threonine deaminase (Sds; P09367), the latter starting the array of connections linking this pathway and other putative BHMT targets. While interactions within the methionine cycle may facilitate metabolite channeling through enzymes of this route, the BHMT-Sds interaction may result in a crosstalk between methionine synthesis and gluconeogenesis, putatively controlling the use of the amino acid for the latter when its levels are low. Only four KEGG pathways were enriched in this network analysis and all are related to metabolic processes, mainly amino acid metabolic routes ([Fig 11B](#pone.0199472.g011){ref-type="fig"}). Results of the cellular component show distribution of the interaction targets among the cytoplasm and other subcellular locations, where the presence of BHMT has not been verified or just recently detected, i.e. the nucleus \[[@pone.0199472.ref011]\]. Therefore, the classical view of BHMT as a cytoplasmic protein should no longer impede the analysis of its putative interactions out of this compartment that, in fact, should be pursued.

The interactions described in the present work may be involved directly or indirectly in HHcy, a condition related to a large variety of diseases that affect tissues with high (e.g. the liver) to undetectable (e.g. brain) BHMT levels \[[@pone.0199472.ref011]\], and for which impaired hepatic Hcy metabolism is the main contributor. Therefore, increases in total plasma Hcy levels may not always correlate with changes in expression, protein or activity levels of BHMT in the affected tissue, but rather reflect hepatic alterations due to different types of injury (i.e. alcohol-induced cirrhosis and drug ingestion), stress (i.e. oxidative stress) or deficiencies in essential nutrients (i.e. B-vitamins). Changes in Hcy metabolism of non-genetic origin commonly result from decreased expression of key enzymes of this pathway, including BHMT as observed in hepatoma, cirrhosis or acute liver injury \[[@pone.0199472.ref006], [@pone.0199472.ref037], [@pone.0199472.ref075]\]. Moreover, this reduced expression correlates with a decrease in cytoplasmic protein levels, putatively changing the hepatic BHMT interaction network. In this line, interactions with MATs or BHMT2 may be favored in the context of HHcy in an attempt to decrease cellular Hcy levels through remethylation, and in order to sustain S-adenosylmethionine production both in the cytoplasm and the nucleus \[[@pone.0199472.ref011], [@pone.0199472.ref037]\]. In parallel, Hcy excess can be converted by methionyl-tRNA synthetase into Hcy thiolactone which reacts with lysine residues rendering protein homocysteinylation, a PTM that has been associated with protein damage and dysfunction \[[@pone.0199472.ref076], [@pone.0199472.ref077]\]. Therefore, putative homocysteinylation of BHMT and/or the interaction targets identified in the present work may preclude their binding to BHMT and, in turn the crosstalk with other pathways. Additionally, HHcy due to liver injury or stress concurs with inflammation, a context in which transglutaminases are activated, thus promoting crosslinking and production of high-Mr complexes that may include i.e. the proinflammatory protein HMGB1 \[[@pone.0199472.ref078]\], in turn translocated to the cytoplasm \[[@pone.0199472.ref036]\]. BHMT is also a substrate of transglutaminase \[[@pone.0199472.ref033], [@pone.0199472.ref051]\], but whether this modification takes place in HHcy remains unknown. We can however speculate that in HHcy a competition for lysine residues may be established between transglutamination and homocysteinylation resulting in either high-Mr complexes or aggregates that cause protein dysfunction. Furthermore, HHcy may also result from the increased Zn^2+^ loss observed in diabetes and alcoholism, as this cation is essential for BHMT activity \[[@pone.0199472.ref025], [@pone.0199472.ref079]\]. Removal of the Zn^2+^ atom leads to an oxidized state of BHMT unable to catalyze Hcy remethylation and structural changes that seem restricted to the active site \[[@pone.0199472.ref023]\]. However, we cannot exclude that other subtle changes take place in the protein structure, putatively affecting protein-protein interaction surfaces such as those involved in ALDOB binding, therefore promoting/precluding the crosstalk between remethylation and glycolysis. In addition, the relevance of the BHMT-Prkaca interaction in HHcy is supported by results of alamandine treatment to revert vascular dysfunction \[[@pone.0199472.ref080]\]. This drug reduces HHcy, whereas inhibition of the PKA signaling pathway decreases its effectivity. Thus, it can be suggested that BHMT phosphorylation by this kinase may be needed for enzyme activation, in turn favoring an increase in Hcy remethylation.

Altogether, we have expanded the network of validated BHMT interaction targets in normal rat liver to include not only enzymes of the methionine cycle, but also of other metabolic pathways and putative regulators ([Fig 11C](#pone.0199472.g011){ref-type="fig"}). Crossregulatory events linking these pathways may contribute to understand the metabolic behavior observed in the large variety of pathologies where HHcy is detected.
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